Protein	B-protein
kinase	I-protein
C	I-protein
activation	O
and	O
protooncogene	B-DNA
expression	O
in	O
differentiation/retrodifferentiation	O
of	O
human	B-cell_line
U-937	I-cell_line
leukemia	I-cell_line
cells	I-cell_line
.	O

Human	B-cell_line
U-937	I-cell_line
leukemia	I-cell_line
cells	I-cell_line
differentiate	O
along	O
the	O
monocytic	B-cell_type
lineage	I-cell_type
following	O
3-day	O
exposures	O
to	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
)	O
.	O

This	O
induction	O
of	O
differentiation	O
is	O
accompanied	O
by	O
adherence	O
and	O
loss	O
of	O
proliferation	O
,	O
as	O
well	O
as	O
expression/repression	O
of	O
differentiation-associated	B-DNA
genes	I-DNA
.	O

Long	O
term	O
culture	O
of	O
TPA-differentiated	B-cell_type
U-937	I-cell_type
cells	I-cell_type
in	O
the	O
absence	O
of	O
phorbol	O
ester	O
for	O
32-36	O
days	O
resulted	O
in	O
a	O
process	O
of	O
retrodifferentiation	O
.	O

The	O
retrodifferentiated	O
cells	O
detached	O
from	O
the	O
substrate	O
and	O
reinitiated	O
proliferation	O
.	O

Other	O
cellular	O
parameters	O
,	O
such	O
as	O
glycosidase	O
activities	O
,	O
cytokine	B-protein
release	O
,	O
and	O
filament	O
expression	O
,	O
returned	O
to	O
levels	O
similar	O
to	O
that	O
observed	O
in	O
uninduced	B-cell_type
cells	I-cell_type
.	O

Treatment	O
of	O
U-937	B-cell_line
cells	I-cell_line
with	O
TPA	O
resulted	O
in	O
a	O
rapid	O
translocation	O
of	O
protein	B-protein
kinase	I-protein
C	I-protein
(	O
PKC	B-protein
)	O
from	O
the	O
cytosol	O
to	O
cell	O
membrane	O
fractions	O
within	O
2-8	O
min	O
.	O

Increased	O
levels	O
of	O
membrane-associated	O
PKC	B-protein
activity	O
persisted	O
until	O
17-29	O
days	O
.	O

However	O
,	O
longer	O
periods	O
of	O
incubation	O
were	O
associated	O
with	O
a	O
return	O
to	O
the	O
distribution	O
of	O
PKC	B-protein
in	O
control	O
cells	O
.	O

Activation	O
of	O
PKC	B-protein
has	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
certain	O
immediate	B-DNA
early	I-DNA
response	I-DNA
genes	I-DNA
,	O
and	O
in	O
the	O
present	O
studies	O
,	O
TPA	O
rapidly	O
induced	O
c-fos	B-DNA
and	O
c-jun	B-DNA
gene	I-DNA
expression	I-DNA
.	O

Levels	O
of	O
c-fos	B-RNA
and	I-RNA
c-jun	I-RNA
transcripts	I-RNA
remained	O
elevated	O
during	O
periods	O
of	O
PKC	B-protein
activation	O
and	O
also	O
returned	O
to	O
levels	O
observed	O
in	O
control	O
cells	O
by	O
30-36	O
days	O
,	O
when	O
the	O
cells	O
entered	O
retrodifferentiation	O
.	O

Staurosporine	O
,	O
a	O
nonspecific	O
inhibitor	O
of	O
PKC	B-protein
,	O
partially	O
blocked	O
TPA-induced	O
adherence	O
and	O
growth	O
inhibition	O
and	O
concomitantly	O
prevented	O
TPA-induced	O
c-fos	O
and	O
c-jun	O
gene	O
expression	O
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Vol	NULL
.	NULL

2	NULL
,	NULL
541-548	NULL
,	NULL
November	NULL
1991	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
541	NULL
Protein	NULL
Kinase	NULL
C	NULL
Activation	NULL
and	NULL
Protooncogene	NULL
Expression	NULL
in	NULL
of	NULL
Human	NULL
U-937	NULL
Leukemia	NULL
Cells	NULL
!	NULL

Ralf	NULL
Hass	NULL
,	NULL
``	NULL
Hans-Jurgen	NULL
Pfannkuche	NULL
,	NULL
Surender	NULL
Kharbanda	NULL
,	NULL
Hisato	NULL
Gunji	NULL
,	NULL
Ginter	NULL
Meyer	NULL
,	NULL
Andreas	NULL
Hartmann	NULL
,	NULL
Hiroyoshi	NULL
Hidaka	NULL
,	NULL
Klaus	NULL
Resch	NULL
,	NULL
Donald	NULL
Kufe	NULL
,	NULL
and	NULL
Margarete	NULL
Goppelt-Strube	NULL
Department	NULL
of	NULL
Molecular	NULL
Pharmacology	NULL
,	NULL
Medical	NULL
School	NULL
,	NULL
D-3000	NULL
Hannover	NULL
,	NULL
Federal	NULL
Republic	NULL
of	NULL
Germany	NULL
[	NULL
R.	NULL
H.	NULL
,	NULL
H-J	NULL
.	NULL

P.	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
M.	NULL
G-S.	NULL
]	NULL
;	NULL
Laboratory	NULL
of	NULL
Clinical	NULL
Pharmacology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
[	NULL
R.	NULL
H.	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
H.	NULL
G.	NULL
,	NULL
D.	NULL
K.	NULL
]	NULL
;	NULL
Department	NULL
of	NULL
Virology	NULL
,	NULL
German	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
D-6900	NULL
Heidelberg	NULL
,	NULL
Federal	NULL
Republic	NULL
of	NULL
Germany	NULL
[	NULL
A.	NULL
H.	NULL
]	NULL
;	NULL
and	NULL
Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
Nagoya	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Nagoya	NULL
466	NULL
,	NULL
Japan	NULL
[	NULL
H.	NULL
H.	NULL
]	NULL
Abstract	NULL
Human	NULL
U-937	NULL
leukemia	NULL
cells	NULL
differentiate	NULL
along	NULL
the	NULL
monocytic	NULL
lineage	NULL
following	NULL
3-day	NULL
exposures	NULL
to	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
.	NULL

This	NULL
induction	NULL
of	NULL
differentiation	NULL
is	NULL
accompanied	NULL
by	NULL
adherence	NULL
and	NULL
loss	NULL
of	NULL
proliferation	NULL
,	NULL
as	NULL
well	NULL
as	NULL
expression/repression	NULL
of	NULL
differentiation-associated	NULL
genes	NULL
.	NULL

Long	NULL
term	NULL
culture	NULL
of	NULL
TPA-differentiated	NULL
U-937	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
phorbol	NULL
ester	NULL
for	NULL
32-36	NULL
days	NULL
resulted	NULL
in	NULL
a	NULL
process	NULL
of	NULL
retrodifferentiation	NULL
.	NULL

The	NULL
retrodifferentiated	NULL
cells	NULL
detached	NULL
from	NULL
the	NULL
substrate	NULL
and	NULL
reinitiated	NULL
proliferation	NULL
.	NULL

Other	NULL
cellular	NULL
parameters	NULL
,	NULL
such	NULL
as	NULL
glycosidase	NULL
activities	NULL
,	NULL
cytokine	NULL
release	NULL
,	NULL
and	NULL
filament	NULL
expression	NULL
,	NULL
returned	NULL
to	NULL
levels	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
uninduced	NULL
cells	NULL
.	NULL

Treatment	NULL
of	NULL
U-937	NULL
cells	NULL
with	NULL
TPA	NULL
resulted	NULL
in	NULL
a	NULL
rapid	NULL
translocation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
cell	NULL
membrane	NULL
fractions	NULL
within	NULL
2-8	NULL
min	NULL
.	NULL

Increased	NULL
levels	NULL
of	NULL
membrane-associated	NULL
PKC	NULL
activity	NULL
persisted	NULL
until	NULL
17-29	NULL
days	NULL
.	NULL

However	NULL
,	NULL
longer	NULL
periods	NULL
of	NULL
incubation	NULL
were	NULL
associated	NULL
with	NULL
a	NULL
return	NULL
to	NULL
the	NULL
distribution	NULL
of	NULL
PKC	NULL
in	NULL
control	NULL
cells	NULL
.	NULL

Activation	NULL
of	NULL
PKC	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
certain	NULL
immediate	NULL
early	NULL
response	NULL
genes	NULL
,	NULL
and	NULL
in	NULL
the	NULL
present	NULL
studies	NULL
,	NULL
TPA	NULL
rapidly	NULL
induced	NULL
c-fos	NULL
and	NULL
c-jun	NULL
gene	NULL
expression	NULL
.	NULL

Levels	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
transcripts	NULL
remained	NULL
elevated	NULL
during	NULL
periods	NULL
of	NULL
PKC	NULL
activation	NULL
and	NULL
also	NULL
returned	NULL
to	NULL
levels	NULL
observed	NULL
in	NULL
control	NULL
cells	NULL
by	NULL
30-36	NULL
days	NULL
,	NULL
when	NULL
the	NULL
cells	NULL
entered	NULL
retrodifferentiation	NULL
.	NULL

Staurosporine	NULL
,	NULL
a	NULL
nonspecific	NULL
inhibitor	NULL
of	NULL
PKC	NULL
,	NULL
partially	NULL
blocked	NULL
TPA-induced	NULL
adherence	NULL
and	NULL
growth	NULL
inhibition	NULL
and	NULL
concomitantly	NULL
prevented	NULL
TPA-induced	NULL
c-fos	NULL
and	NULL
c-jun	NULL
gene	NULL
expression	NULL
.	NULL

These	NULL
findings	NULL
thus	NULL
suggest	NULL
that	NULL
PKC	NULL
activation	NULL
is	NULL
involved	NULL
in	NULL
both	NULL
regulation	NULL
of	NULL
early	NULL
response	NULL
gene	NULL
expression	NULL
and	NULL
controlling	NULL
the	NULL
state	NULL
of	NULL
Received	NULL
3/29/91	NULL
.	NULL

'This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grant	NULL
SFB244/B5	NULL
and	NULL
a	NULL
postdoctoral	NULL
fellowship	NULL
(	NULL
R.	NULL
H.	NULL
)	NULL
from	NULL
the	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
.	NULL

*	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
,	NULL
at	NULL
Laboratory	NULL
of	NULL
Clinical	NULL
Pharmacology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
44	NULL
Binney	NULL
Street	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115.	NULL
development	NULL
during	NULL
differentiation/retrodifferentiation	NULL
of	NULL
U-937	NULL
cells	NULL
.	NULL

Introduction	NULL
Human	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
(	NULL
HL-60	NULL
,	NULL
U-937	NULL
)	NULL
differentiate	NULL
along	NULL
the	NULL
monocytic	NULL
lineage	NULL
following	NULL
exposure	NULL
to	NULL
phorbol	NULL
esters	NULL
such	NULL
as	NULL
TPA	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
differentiated	NULL
monocytic	NULL
phenotype	NULL
is	NULL
characterized	NULL
by	NULL
growth	NULL
inhibi-tion	NULL
,	NULL
adherence	NULL
,	NULL
loss	NULL
of	NULL
cell	NULL
surface	NULL
transferrin	NULL
receptors	NULL
,	NULL
induction	NULL
of	NULL
a-naphthyl	NULL
acetate	NULL
esterase	NULL
staining	NULL
,	NULL
and	NULL
increases	NULL
in	NULL
monocyte	NULL
surface	NULL
markers	NULL
(	NULL
3	NULL
)	NULL
.	NULL

TPA-induced	NULL
differentiation	NULL
of	NULL
some	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
lines	NULL
is	NULL
also	NULL
associated	NULL
with	NULL
down-regulation	NULL
of	NULL
c-myc	NULL
and	NULL
c-myb	NULL
gene	NULL
expression	NULL
,	NULL
as	NULL
well	NULL
as	NULL
induction	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
immediate	NULL
early	NULL
response	NULL
genes	NULL
(	NULL
4-6	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
genes	NULL
code	NULL
for	NULL
cell	NULL
nucleus-associated	NULL
products	NULL
,	NULL
TPA-induced	NULL
differentiation	NULL
is	NULL
also	NULL
associated	NULL
with	NULL
subsequent	NULL
increases	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
products	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
and	NULL
function	NULL
of	NULL
monocytes	NULL
.	NULL

For	NULL
exam-ple	NULL
,	NULL
TPA	NULL
increases	NULL
levels	NULL
of	NULL
transcripts	NULL
coding	NULL
for	NULL
the	NULL
monocyte	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
M-CSF	NULL
,	NULL
CSF-1	NULL
)	NULL
,	NULL
the	NULL
monocyte	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
(	NULL
c-fms	NULL
gene	NULL
product	NULL
)	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
TPA-induced	NULL
appearance	NULL
of	NULL
the	NULL
monocytic	NULL
phenotype	NULL
is	NULL
associated	NULL
with	NULL
changes	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
both	NULL
early	NULL
and	NULL
later	NULL
response	NULL
genes	NULL
.	NULL

TPA	NULL
activates	NULL
calcium-	NULL
and	NULL
phospholipid-dependent	NULL
PKC	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
role	NULL
of	NULL
this	NULL
enzyme	NULL
in	NULL
regulating	NULL
events	NULL
associated	NULL
with	NULL
monocytic	NULL
differentiation	NULL
has	NULL
remained	NULL
unclear	NULL
.	NULL

Bryostatin	NULL
1	NULL
,	NULL
a	NULL
macrocyclic	NULL
lactone	NULL
isolated	NULL
from	NULL
a	NULL
marine	NULL
bryozoan	NULL
,	NULL
also	NULL
induces	NULL
translocation	NULL
of	NULL
PKC	NULL
and	NULL
monocytic	NULL
differentiation	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
phospholipase	NULL
C-mediated	NULL
formation	NULL
of	NULL
diacylglyc-erol	NULL
,	NULL
the	NULL
endogenous	NULL
activator	NULL
of	NULL
PKC	NULL
,	NULL
is	NULL
associated	NULL
with	NULL
transient	NULL
induction	NULL
of	NULL
certain	NULL
genes	NULL
that	NULL
are	NULL
also	NULL
induced	NULL
during	NULL
TPA	NULL
treatment	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
sphingoid	NULL
bases	NULL
and	NULL
palmitoyl	NULL
carnitine	NULL
inhibit	NULL
PKC	NULL
activation	NULL
and	NULL
block	NULL
TPA-induced	NULL
differentiation	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
have	NULL
supported	NULL
the	NULL
involvement	NULL
of	NULL
PKC	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
PKC	NULL
activators	NULL
on	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
have	NULL
been	NULL
examined	NULL
in	NULL
most	NULL
studies	NULL
at	NULL
varying	NULL
intervals	NULL
through	NULL
several	NULL
days	NULL
after	NULL
induction	NULL
of	NULL
differentiation	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
work	NULL
has	NULL
demonstrated	NULL
that	NULL
U-937	NULL
cells	NULL
induced	NULL
to	NULL
differentiate	NULL
by	NULL
TPA	NULL
revert	NULL
back	NULL
to	NULL
the	NULL
undifferentiated	NULL
phenotype	NULL
when	NULL
cultured	NULL
for	NULL
periods	NULL
of	NULL
more	NULL
than	NULL
30	NULL
days	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
this	NULL
agent	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
process	NULL
of	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TPA	NULL
,	NULL
12-O-tetradecanoylphorbol-13-ace-tate	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
(	NULL
s	NULL
)	NULL
;	NULL
TNF-a	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
;	NULL
IL-18	NULL
,	NULL
interleukin	NULL
18	NULL
;	NULL
PBS	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
;	NULL
SDS	NULL
,	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
;	NULL
cDNA	NULL
,	NULL
complementary	NULL
DNA	NULL
.	NULL

542	NULL
PKC	NULL
Activation	NULL
in	NULL
U-937	NULL
Differentiation	NULL
and	NULL
Retrodifferentiation	NULL
retrodifferentiation	NULL
characterized	NULL
by	NULL
apparent	NULL
reversibil-ity	NULL
of	NULL
all	NULL
parameters	NULL
which	NULL
have	NULL
been	NULL
altered	NULL
during	NULL
a	NULL
previous	NULL
differentiation	NULL
event	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
properties	NULL
of	NULL
the	NULL
retrodifferentiated	NULL
cells	NULL
were	NULL
indistinguishable	NULL
from	NULL
untreated	NULL
control	NULL
cells	NULL
(	NULL
13	NULL
)	NULL
.	NULL

There	NULL
are	NULL
presently	NULL
few	NULL
insights	NULL
available	NULL
regarding	NULL
the	NULL
mechanisms	NULL
responsible	NULL
for	NULL
this	NULL
retrodifferentiation	NULL
of	NULL
TPA-treated	NULL
U-937	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
although	NULL
PKC	NULL
activation	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
,	NULL
the	NULL
relationship	NULL
between	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
enzyme	NULL
and	NULL
retrodifferentiation	NULL
is	NULL
unknown	NULL
.	NULL

The	NULL
present	NULL
studies	NULL
have	NULL
examined	NULL
activation	NULL
of	NULL
PKC	NULL
during	NULL
differentiation/retro-differentiation	NULL
,	NULL
as	NULL
well	NULL
as	NULL
changes	NULL
in	NULL
phenotype	NULL
and	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
a	NULL
relationship	NULL
between	NULL
activation	NULL
of	NULL
PKC	NULL
and	NULL
c-fos/c-jun	NULL
gene	NULL
expression	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
this	NULL
enzyme	NULL
in	NULL
the	NULL
maintenance	NULL
and	NULL
reversion	NULL
of	NULL
the	NULL
differentiated	NULL
monocytic	NULL
phenotye	NULL
.	NULL

Results	NULL
Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
TPA	NULL
induces	NULL
monocytic	NULL
differentiation	NULL
in	NULL
U-937	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

This	NULL
induction	NULL
is	NULL
followed	NULL
by	NULL
a	NULL
process	NULL
of	NULL
retrodifferentiation	NULL
(	NULL
13	NULL
)	NULL
.	NULL

TPA	NULL
activates	NULL
the	NULL
Ca**-	NULL
and	NULL
phospholipid-dependent	NULL
PKC	NULL
by	NULL
translocating	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
enzyme	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
cell	NULL
membrane	NULL
fractions	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
differentiation/retrodifferentiation	NULL
is	NULL
related	NULL
to	NULL
these	NULL
effects	NULL
of	NULL
TPA	NULL
,	NULL
we	NULL
first	NULL
studied	NULL
activation	NULL
of	NULL
PKC	NULL
in	NULL
U-937	NULL
cells	NULL
by	NULL
this	NULL
agent	NULL
.	NULL

Approximately	NULL
90	NULL
%	NULL
of	NULL
the	NULL
total	NULL
PKC	NULL
activity	NULL
was	NULL
detectable	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
U-937	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
treatment	NULL
with	NULL
TPA	NULL
was	NULL
associated	NULL
with	NULL
translocation	NULL
of	NULL
this	NULL
activity	NULL
to	NULL
the	NULL
cell	NULL
membrane	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
concentration	NULL
of	NULL
TPA	NULL
.	NULL

Whereas	NULL
concentrations	NULL
of	NULL
107°	NULL
m	NULL
or	NULL
less	NULL
had	NULL
little	NULL
,	NULL
if	NULL
any	NULL
,	NULL
effect	NULL
,	NULL
exposures	NULL
to	NULL
5	NULL
X	NULL
107°	NULL
m	NULL
and	NULL
higher	NULL
TPA	NULL
concentrations	NULL
were	NULL
associated	NULL
with	NULL
PKC	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
corresponded	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
varying	NULL
concentrations	NULL
of	NULL
TPA	NULL
to	NULL
induce	NULL
a	NULL
differentiated	NULL
monocyte	NULL
phenotype	NULL
.	NULL

Thus	NULL
,	NULL
5	NULL
X	NULL
107°	NULL
m	NULL
TPA	NULL
was	NULL
the	NULL
lowest	NULL
concentration	NULL
found	NULL
to	NULL
activate	NULL
PKC	NULL
and	NULL
induce	NULL
monocytic	NULL
differentiation	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
5	NULL
X	NULL
107°	NULL
m	NULL
TPA	NULL
on	NULL
PKC	NULL
translocation	NULL
were	NULL
measured	NULL
over	NULL
time	NULL
to	NULL
determine	NULL
whether	NULL
activation	NULL
of	NULL
this	NULL
enzyme	NULL
is	NULL
related	NULL
to	NULL
differentiation	NULL
and	NULL
retrodifferentiation	NULL
.	NULL

Translocation	NULL
of	NULL
PKC	NULL
activity	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
cell	NULL
membrane	NULL
was	NULL
detectable	NULL
after	NULL
2	NULL
min	NULL
of	NULL
TPA	NULL
exposure	NULL
,	NULL
and	NULL
nearly	NULL
90	NULL
%	NULL
of	NULL
the	NULL
PKC	NULL
activity	NULL
was	NULL
translocated	NULL
by	NULL
8-15	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

An	NULL
increase	NULL
in	NULL
membrane-associated	NULL
PKC	NULL
activity	NULL
persisted	NULL
for	NULL
up	NULL
to	NULL
29	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
increases	NULL
in	NULL
cytosolic	NULL
activity	NULL
were	NULL
also	NULL
detectable	NULL
by	NULL
17	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
distribution	NULL
of	NULL
PKC	NULL
activity	NULL
in	NULL
both	NULL
the	NULL
cytosol	NULL
and	NULL
cell	NULL
membrane	NULL
returned	NULL
to	NULL
near	NULL
that	NULL
of	NULL
untreated	NULL
cells	NULL
by	NULL
30-36	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
distribution	NULL
of	NULL
PKC	NULL
proteins	NULL
in	NULL
subcellular	NULL
compartments	NULL
was	NULL
analyzed	NULL
by	NULL
Western	NULL
blots	NULL
of	NULL
long	NULL
term	NULL
cultured	NULL
,	NULL
differentiated	NULL
U-937	NULL
cells	NULL
.	NULL

Cytosolic	NULL
PKCB	NULL
was	NULL
down-regulated	NULL
between	NULL
5	NULL
min	NULL
and	NULL
1	NULL
h	NULL
after	NULL
TPA	NULL
treatment	NULL
.	NULL

However	NULL
,	NULL
following	NULL
culture	NULL
of	NULL
induced	NULL
cells	NULL
for	NULL
25	NULL
days	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TPA	NULL
,	NULL
PKCB	NULL
reappeared	NULL
in	NULL
the	NULL
cytosol	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
80	NULL
kDa	NULL
PKCB8	NULL
protein	NULL
in	NULL
membrane	NULL
preparations	NULL
of	NULL
uninduced	NULL
and	NULL
TPA-induced	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
although	NULL
MC-1a	NULL
and	NULL
MC-3a	NULL
demonstrated	NULL
reactivity	NULL
with	NULL
rat	NULL
brain	NULL
A	NULL
C	NULL
B	NULL
Ele	NULL
1000	NULL
€	NULL
3	NULL
8	NULL
9	NULL
g	NULL
500	NULL
0	NULL
6	NULL
bP	NULL
_	NULL
sao	NULL
P	NULL
9°	NULL
sagt	NULL
pB	NULL
sap-8	NULL
concentration	NULL
TPA	NULL
[	NULL
M	NULL
]	NULL
B	NULL
[	NULL
I	NULL
e	NULL
/A	NULL
e	NULL
2	NULL
,	NULL
7d	NULL
N	NULL
A	NULL
AIF	NULL
1000	NULL
!	NULL

T	NULL
A	NULL
il	NULL
[	NULL
5	NULL
bola	NULL
<	NULL
I	NULL
$	NULL
00	NULL
1	NULL
v	NULL
‘	NULL
o	NULL
Pos	NULL
‘	NULL
~_—¥_	NULL
‘	NULL
*	NULL
»	NULL
;	NULL
<	NULL
\Jﬁ/	NULL
’	NULL
J	NULL
H	NULL
3003	NULL
J	NULL
+	NULL
*	NULL
1	NULL
__	NULL
I	NULL
1	NULL
-	NULL
i	NULL
-	NULL
Lue	NULL
*	NULL
R	NULL
[	NULL
o	NULL
po	NULL
-	NULL
_-	NULL
.	NULL

4	NULL
*	NULL
\	NULL
hal	NULL
J	NULL
]	NULL
.	NULL

.	NULL

#	NULL
,	NULL
heat	NULL
~	NULL
0	NULL
55	NULL
so	NULL
so	NULL
ourc	NULL
``	NULL
os	NULL
n	NULL
=	NULL
23	NULL
ra	NULL
``	NULL
36	NULL
(	NULL
U	NULL
$	NULL
37	NULL
retro	NULL
minutes	NULL
.	NULL

after	NULL
days	NULL
.	NULL

after	NULL
|	NULL
treatment	NULL
TPA-treat	NULL
ment	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

_	NULL
A	NULL
,	NULL
translocation	NULL
of	NULL
PKC	NULL
in	NULL
U-937	NULL
cells	NULL
by	NULL
treatment	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
TPA	NULL
for	NULL
72	NULL
h.	NULL
®	NULL
,	NULL
membrane-associated	NULL
PKC	NULL
activity	NULL
;	NULL
O	NULL
,	NULL
cytosolic	NULL
PKC	NULL
activity	NULL
.	NULL

Data	NULL
represent	NULL
means	NULL
of	NULL
one	NULL
experiment	NULL
in	NULL
triplicates	NULL
.	NULL

B	NULL
,	NULL
time	NULL
course	NULL
of	NULL
PKC	NULL
activation	NULL
in	NULL
U-937	NULL
cells	NULL
after	NULL
treatment	NULL
with	NULL
5	NULL
x	NULL
107°	NULL
m	NULL
TPA	NULL
.	NULL

B	NULL
,	NULL
membrane-associated	NULL
PKC	NULL
activity	NULL
;	NULL
0	NULL
,	NULL
cytosolic	NULL
PKC	NULL
activity	NULL
.	NULL

Data	NULL
represent	NULL
mean	NULL
+	NULL
SD	NULL
(	NULL
bars	NULL
)	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

cytosol	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
binding	NULL
of	NULL
these	NULL
monoclonal	NULL
antibodies	NULL
to	NULL
cytosolic	NULL
or	NULL
membrane	NULL
fractions	NULL
of	NULL
the	NULL
U-937	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
PKC-isoenzyme	NULL
mRNA	NULL
levels	NULL
during	NULL
long	NULL
term	NULL
culture	NULL
of	NULL
TPA-treated	NULL
U-937	NULL
cells	NULL
revealed	NULL
low	NULL
levels	NULL
of	NULL
PKCa	NULL
and	NULL
PKCy	NULL
in	NULL
control	NULL
cells	NULL
and	NULL
cells	NULL
treated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
TPA	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
3-day	NULL
exposure	NULL
to	NULL
TPA	NULL
was	NULL
associated	NULL
with	NULL
enhanced	NULL
expression	NULL
of	NULL
PKCa	NULL
and	NULL
PKCy	NULL
mRNAs	NULL
.	NULL

However	NULL
,	NULL
when	NULL
the	NULL
cells	NULL
underwent	NULL
retrodifferentiation	NULL
between	NULL
30	NULL
and	NULL
36	NULL
days	NULL
,	NULL
PKCa	NULL
and	NULL
PKCy	NULL
expression	NULL
declined	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
control	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
levels	NULL
of	NULL
a	NULL
transcript	NULL
of	NULL
approximately	NULL
4.0	NULL
kb	NULL
remained	NULL
without	NULL
apparent	NULL
change	NULL
during	NULL
the	NULL
course	NULL
of	NULL
the	NULL
experiment	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggested	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
TPA	NULL
on	NULL
PKC	NULL
activation	NULL
in	NULL
U-937	NULL
cells	NULL
are	NULL
reversible	NULL
.	NULL

TPA	NULL
activates	NULL
PKC	NULL
by	NULL
binding	NULL
to	NULL
this	NULL
enzyme	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
further	NULL
studies	NULL
were	NULL
performed	NULL
to	NULL
determine	NULL
whether	NULL
binding	NULL
of	NULL
TPA	NULL
corresponded	NULL
to	NULL
translocation	NULL
of	NULL
PKC	NULL
activity	NULL
.	NULL

U-937	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
X	NULL
107°	NULL
m	NULL
|HIJTPA	NULL
for	NULL
3	NULL
days	NULL
and	NULL
then	NULL
maintained	NULL
in	NULL
drug-free	NULL
medium	NULL
.	NULL

Lipid	NULL
extraction	NULL
and	NULL
analysis	NULL
by	NULL
thin	NULL
layer	NULL
chromatography	NULL
revealed	NULL
that	NULL
11	NULL
+	NULL
0.9	NULL
%	NULL
(	NULL
mean	NULL
+	NULL
SD	NULL
;	NULL
n	NULL
=	NULL
4	NULL
)	NULL
of	NULL
the	NULL
labeled	NULL
TPA	NULL
was	NULL
bound	NULL
during	NULL
the	NULL
first	NULL
3	NULL
days	NULL
.	NULL

However	NULL
,	NULL
there	NULL
was	NULL
a	NULL
progressive	NULL
decline	NULL
in	NULL
the	NULL
extent	NULL
of	NULL
TPA	NULL
binding	NULL
over	NULL
24	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Although	NULL
less	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
543	NULL
>	NULL
>	NULL
rat	NULL
brain	NULL
U-937	NULL
rat	NULL
brain	NULL
9	NULL
3	NULL
-	NULL
!	NULL

<	NULL
p	NULL
[	NULL
-+	NULL
.	NULL

an	NULL
?	NULL

”	NULL
ii	NULL
g	NULL
cytosol	NULL
C	NULL
f	NULL
ilps	NULL
PF	NULL
kDa	NULL
#	NULL
0	NULL
mn	NULL
~	NULL
co	NULL
23	NULL
,	NULL
a	NULL
membranes	NULL
-	NULL
h	NULL
age	NULL
apa	NULL
w+	NULL
t-d	NULL
B	NULL
&	NULL
.	NULL

»	NULL
ceo	NULL
v	NULL
2	NULL
B	NULL
2	NULL
8	NULL
D	NULL
im	NULL
a	NULL
-	NULL
®	NULL
-	NULL
a	NULL
o	NULL
~	NULL
28	NULL
S	NULL
-	NULL
k	NULL
*	NULL
&	NULL
PKCa	NULL
s	NULL
ya	NULL
++	NULL
to	NULL
«	NULL
:	NULL
CAHH	NULL
~	NULL
HH	NULL
28	NULL
S	NULL
-	NULL
PKCJ	NULL
185	NULL
28	NULL
S	NULL
-	NULL
PKCy	NULL
185	NULL
28	NULL
S	NULL
-	NULL
28	NULL
S	NULL
RNA	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

A	NULL
,	NULL
PKCB	NULL
Western	NULL
blots	NULL
of	NULL
cytosolic	NULL
and	NULL
membrane	NULL
fractions	NULL
from	NULL
TPA-treated	NULL
U-937	NULL
cells	NULL
and	NULL
long	NULL
term	NULL
cultured	NULL
,	NULL
TPA-differentiated	NULL
cells	NULL
.	NULL

Rat	NULL
brain	NULL
cytosol	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

B	NULL
,	NULL
expression	NULL
pattern	NULL
of	NULL
PKCa	NULL
,	NULL
PKC3	NULL
,	NULL
and	NULL
PKCy	NULL
mRNAs	NULL
during	NULL
long	NULL
term	NULL
culture	NULL
of	NULL
TPA-differentiated	NULL
U-937	NULL
cells	NULL
.	NULL

Staining	NULL
of	NULL
the	NULL
285	NULL
RNA	NULL
demonstrates	NULL
equal	NULL
loading	NULL
of	NULL
RNA	NULL
.	NULL

than	NULL
50	NULL
%	NULL
of	NULL
the	NULL
cell-associated	NULL
remained	NULL
after	NULL
10	NULL
days	NULL
,	NULL
there	NULL
was	NULL
>	NULL
90	NULL
%	NULL
decrease	NULL
in	NULL
TPA	NULL
binding	NULL
by	NULL
24	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
the	NULL
migration	NULL
of	NULL
fresh	NULL
[	NULL
PH	NULL
]	NULL
JTPA	NULL
on	NULL
a	NULL
reference	NULL
lane	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
the	NULL
peaks	NULL
of	NULL
the	NULL
radioactivity	NULL
always	NULL
appeared	NULL
at	NULL
the	NULL
same	NULL
point	NULL
(	NULL
R	NULL
,	NULL
value	NULL
=	NULL
0.3	NULL
)	NULL
.	NULL

The	NULL
decline	NULL
in	NULL
incorporated	NULL
H	NULL
]	NULL
TPA	NULL
during	NULL
long	NULL
term	NULL
culture	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
progressive	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
tritium	NULL
in	NULL
the	NULL
culture	NULL
supernatant	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
with	NULL
the	NULL
studies	NULL
of	NULL
PKC	NULL
activation	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
TPA	NULL
binding	NULL
and	NULL
translocation	NULL
of	NULL
enzyme	NULL
activity	NULL
are	NULL
related	NULL
and	NULL
reversible	NULL
.	NULL

TPA	NULL
binding	NULL
and	NULL
PKC	NULL
activation	NULL
were	NULL
compared	NULL
with	NULL
changes	NULL
in	NULL
cellular	NULL
parameters	NULL
of	NULL
a	NULL
differentiated	NULL
U-937	NULL
phenotype	NULL
.	NULL

The	NULL
initial	NULL
6	NULL
days	NULL
following	NULL
TPA	NULL
exposure	NULL
were	NULL
associated	NULL
with	NULL
(	NULL
a	NULL
)	NULL
decreases	NULL
in	NULL
B-galactosidase	NULL
and	NULL
a-mannosidase	NULL
activities	NULL
;	NULL
(	NULL
b	NULL
)	NULL
release	NULL
of	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
;	NULL
(	NULL
c	NULL
)	NULL
increases	NULL
in	NULL
mRNA	NULL
expression	NULL
of	NULL
the	NULL
cytosolic	NULL
intermediate	NULL
filament	NULL
protein	NULL
vimentin	NULL
;	NULL
and	NULL
(	NULL
d	NULL
)	NULL
increases	NULL
in	NULL
mRNA	NULL
levels	NULL
of	NULL
the	NULL
nuclear	NULL
intermediate	NULL
filament	NULL
proteins	NULL
lamin	NULL
A	NULL
and	NULL
lamin	NULL
C	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
were	NULL
consistent	NULL
with	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
(	NULL
2	NULL
,	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
incubation	NULL
of	NULL
these	NULL
adherent	NULL
non	NULL
24	NULL
Incubation	NULL
0.1	NULL
0.3	NULL
04	NULL
05	NULL
o	NULL
6	NULL
o	NULL
7	NULL
os	NULL
o	NULL
9	NULL
io	NULL
taays	NULL
)	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

-	NULL
Measurement	NULL
of	NULL
incorporation	NULL
and	NULL
release	NULL
of	NULL
[	NULL
PH	NULL
]	NULL
TPA	NULL
in	NULL
U-937	NULL
cells	NULL
during	NULL
long	NULL
term	NULL
culture	NULL
.	NULL

Data	NULL
represent	NULL
means	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

SD	NULL
was	NULL
always	NULL
below	NULL
10	NULL
%	NULL
of	NULL
the	NULL
means	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
}	NULL
.	NULL

proliferating	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TPA	NULL
for	NULL
up	NULL
to	NULL
24	NULL
days	NULL
was	NULL
associated	NULL
with	NULL
progressive	NULL
increases	NULL
in	NULL
glycosidase	NULL
activities	NULL
and	NULL
down-regulation	NULL
of	NULL
cytokine	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
there	NULL
were	NULL
further	NULL
increases	NULL
in	NULL
expression	NULL
of	NULL
the	NULL
vimentin	NULL
and	NULL
lamin	NULL
A/C	NULL
mRNA	NULL
transcripts	NULL
during	NULL
this	NULL
time	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
each	NULL
of	NULL
these	NULL
parameters	NULL
returned	NULL
to	NULL
pretreatment	NULL
levels	NULL
by	NULL
36	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

These	NULL
phenotypic	NULL
changes	NULL
were	NULL
therefore	NULL
in	NULL
concert	NULL
with	NULL
the	NULL
changes	NULL
in	NULL
the	NULL
level	NULL
of	NULL
PKC	NULL
activation	NULL
.	NULL

Previous	NULL
work	NULL
has	NULL
demonstrated	NULL
that	NULL
monocytic	NULL
differentiation	NULL
is	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
expression	NULL
,	NULL
as	NULL
well	NULL
as	NULL
down-regulation	NULL
of	NULL
c-myb	NULL
transcripts	NULL
.	NULL

In	NULL
the	NULL
present	NULL
studies	NULL
,	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
were	NULL
increased	NULL
within	NULL
2-5	NULL
min	NULL
in	NULL
TPA-treated	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
effect	NULL
of	NULL
TPA	NULL
on	NULL
c-myb	NULL
expression	NULL
during	NULL
1	NULL
h	NULL
of	NULL
exposure	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
c-fos	NULL
transcripts	NULL
was	NULL
detectable	NULL
until	NULL
30	NULL
days	NULL
,	NULL
when	NULL
the	NULL
cells	NULL
entered	NULL
retrodifferentiation	NULL
{	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Similar	NULL
findings	NULL
were	NULL
obtained	NULL
for	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
,	NULL
although	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
was	NULL
biphasic	NULL
with	NULL
maximal	NULL
increases	NULL
at	NULL
12-24	NULL
h	NULL
and	NULL
between	NULL
3	NULL
and	NULL
18	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

As	NULL
for	NULL
c-fos	NULL
expression	NULL
,	NULL
c-jun	NULL
transcripts	NULL
declined	NULL
to	NULL
control	NULL
levels	NULL
by	NULL
36	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

These	NULL
changes	NULL
in	NULL
gene	NULL
expression	NULL
were	NULL
associated	NULL
with	NULL
an	NULL
initial	NULL
decline	NULL
in	NULL
c-myb	NULL
mRNA	NULL
levels	NULL
after	NULL
24-48	NULL
h	NULL
and	NULL
then	NULL
subsequent	NULL
increases	NULL
to	NULL
levels	NULL
similar	NULL
to	NULL
those	NULL
in	NULL
untreated	NULL
cells	NULL
by	NULL
36	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
reappearance	NULL
of	NULL
c-myb	NULL
transcripts	NULL
was	NULL
associated	NULL
with	NULL
loss	NULL
of	NULL
cell	NULL
adherence	NULL
and	NULL
reinitiation	NULL
of	NULL
proliferation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Further	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
staurosporine	NULL
,	NULL
a	NULL
nonspecific	NULL
inhibitor	NULL
of	NULL
PKC	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
to	NULL
determine	NULL
whether	NULL
activation	NULL
of	NULL
this	NULL
enzyme	NULL
is	NULL
necessary	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
differentiated	NULL
phenotype	NULL
.	NULL

U-937	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
varying	NULL
concentrations	NULL
of	NULL
staurosporine	NULL
before	NULL
adding	NULL
TPA	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
staurosporine	NULL
blocked	NULL
TPA-induced	NULL
adherence	NULL
in	NULL
a	NULL
con-centration-dependent	NULL
manner	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Similar	NULL
findings	NULL
were	NULL
obtained	NULL
when	NULL
monitoring	NULL
proliferation	NULL
.	NULL

Although	NULL
3	NULL
X	NULL
10	NULL
%	NULL
m	NULL
and	NULL
6	NULL
x	NULL
107	NULL
m	NULL
concentrations	NULL
had	NULL
little	NULL
,	NULL
if	NULL
any	NULL
,	NULL
effect	NULL
on	NULL
TPA-induced	NULL
growth	NULL
arrest	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
[	NULL
H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
,	NULL
107°	NULL
m	NULL
staurosporine	NULL
partially	NULL
blocked	NULL
the	NULL
growth-inhibitory	NULL
effects	NULL
of	NULL
this	NULL
agent	NULL
,	NULL
whereas	NULL
no	NULL
significant	NULL
effect	NULL
was	NULL
detectable	NULL
on	NULL
uninduced	NULL
U-937	NULL
cells	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

High	NULL
concentrations	NULL
of	NULL
§44	NULL
-	NULL
PKC	NULL
Activation	NULL
in	NULL
U-937	NULL
Differentiation	NULL
and	NULL
Retrodifferentiation	NULL
@	NULL
wo	NULL
m	NULL
80	NULL
)	NULL
a	NULL
E	NULL
§	NULL
f	NULL
o	NULL
U	NULL
2	NULL
2	NULL
§	NULL
S	NULL
315	NULL
o	NULL
@	NULL
8	NULL
$	NULL
6	NULL
w	NULL
Swizz	NULL
.	NULL

3	NULL
6	NULL
,	NULL
7	NULL
2	NULL
G	NULL
o	NULL
20	NULL
y	NULL
C1	NULL
§§16	NULL
€	NULL
3	NULL
12	NULL
_	NULL
#	NULL
o	NULL
5	NULL
oB	NULL
$	NULL
B	NULL
}	NULL
Lt	NULL
g	NULL
I	NULL
z	NULL
u	NULL
p	NULL
)	NULL
=	NULL
&	NULL
U937	NULL
3	NULL
6	NULL
8	NULL
10	NULL
12	NULL
14	NULL
16	NULL
18	NULL
20	NULL
22	NULL
24	NULL
26	NULL
28	NULL
30	NULL
32	NULL
x	NULL
%	NULL
days	NULL
post	NULL
TPA-treatment	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

-	NULL
Time	NULL
course	NULL
of	NULL
glycosidase	NULL
activities	NULL
,	NULL
cytokine	NULL
release	NULL
,	NULL
and	NULL
intermediate	NULL
filament	NULL
mRNA	NULL
expression	NULL
during	NULL
long	NULL
term	NULL
culture	NULL
of	NULL
TPA-differentiated	NULL
U-937	NULL
cells	NULL
in	NULL
comparison	NULL
with	NULL
untreated	NULL
control	NULL
cells	NULL
.	NULL

Specific	NULL
glycosidase	NULL
activities	NULL
:	NULL
8-galactosidase	NULL
(	NULL
@	NULL
)	NULL
and	NULL
a-mannosidase	NULL
(	NULL
0	NULL
)	NULL
.	NULL

Data	NULL
represent	NULL
means	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

SD	NULL
was	NULL
always	NULL
below	NULL
10	NULL
%	NULL
of	NULL
the	NULL
means	NULL
.	NULL

Cytokine	NULL
release	NULL
:	NULL
TNF-a	NULL
(	NULL
0	NULL
)	NULL
and	NULL
(	NULL
@	NULL
)	NULL
.	NULL

Data	NULL
represent	NULL
means	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

SD	NULL
was	NULL
always	NULL
below	NULL
10	NULL
%	NULL
of	NULL
the	NULL
means	NULL
.	NULL

Intermediate	NULL
filament	NULL
mRNA	NULL
expression	NULL
:	NULL
vimentin	NULL
(	NULL
©	NULL
)	NULL
and	NULL
lamin	NULL
A	NULL
(	NULL
0	NULL
)	NULL
.	NULL

staurosporine	NULL
(	NULL
>	NULL
5	NULL
X	NULL
10~°	NULL
m	NULL
)	NULL
significantly	NULL
reduced	NULL
the	NULL
proliferation	NULL
of	NULL
uninduced	NULL
U-937	NULL
cells	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
staurosporine	NULL
on	NULL
changes	NULL
in	NULL
gene	NULL
expression	NULL
were	NULL
also	NULL
examined	NULL
in	NULL
TPA-treated	NULL
U-937	NULL
cells	NULL
.	NULL

Although	NULL
induction	NULL
of	NULL
U-937	NULL
cells	NULL
with	NULL
TPA	NULL
for	NULL
1	NULL
h	NULL
was	NULL
associated	NULL
with	NULL
increases	NULL
in	NULL
c-fos	NULL
and	NULL
c-jun	NULL
transcripts	NULL
,	NULL
pretreatment	NULL
with	NULL
107	NULL
``	NULL
m	NULL
staurosporine	NULL
blocked	NULL
the	NULL
induction	NULL
of	NULL
these	NULL
genes	NULL
in	NULL
part	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
more	NULL
pronounced	NULL
in	NULL
experiments	NULL
with	NULL
2	NULL
x	NULL
10~	NULL
``	NULL
m	NULL
staurosporine	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
staurosporine	NULL
,	NULL
at	NULL
nontoxic	NULL
con-centrations	NULL
,	NULL
is	NULL
a	NULL
weak	NULL
antagonist	NULL
of	NULL
TPA-induced	NULL
changes	NULL
.	NULL

Thus	NULL
,	NULL
TPA-induced	NULL
PKC	NULL
activation	NULL
is	NULL
involved	NULL
at	NULL
least	NULL
partially	NULL
in	NULL
both	NULL
changes	NULL
in	NULL
phenotype	NULL
and	NULL
gene	NULL
expression	NULL
associated	NULL
with	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Discussion	NULL
The	NULL
human	NULL
monoblastoid	NULL
U-937	NULL
cell	NULL
line	NULL
has	NULL
been	NULL
used	NULL
to	NULL
study	NULL
the	NULL
involvement	NULL
of	NULL
PKC	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
protooncogenes	NULL
during	NULL
differentiation	NULL
along	NULL
the	NULL
mono-cyte/macrophage	NULL
lineage	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
U-937	NULL
cells	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
differentiate	NULL
by	NULL
treatment	NULL
with	NULL
5	NULL
X	NULL
10~	NULL
'	NULL
m	NULL
TPA	NULL
for	NULL
72	NULL
h	NULL
(	NULL
2	NULL
)	NULL
.	NULL

This	NULL
concentration	NULL
of	NULL
TPA	NULL
was	NULL
sufficient	NULL
to	NULL
activate	NULL
PKC	NULL
,	NULL
whereas	NULL
lower	NULL
concentrations	NULL
had	NULL
no	NULL
detectable	NULL
effect	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
enzyme	NULL
or	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
.	NULL

The	NULL
differentiated	NULL
U-937	NULL
cell	NULL
phenotype	NULL
was	NULL
maintained	NULL
in	NULL
culture	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TPA	NULL
and	NULL
changing	NULL
the	NULL
medium	NULL
every	NULL
3	NULL
days	NULL
.	NULL

A	NULL
culture	NULL
period	NULL
of	NULL
o	NULL
a	NULL
w	NULL
o	NULL
c	NULL
C	NULL
«	NULL
-	NULL
28S-	NULL
c-fos	NULL
18Ss-28S-	NULL
f	NULL
it	NULL
u	NULL
c-jun	NULL
28S-	NULL
c-myb	NULL
18S-	NULL
Control	NULL
1	NULL
8	NULL
3	NULL
-	NULL
WW	NULL
Wl	NULL
om	NULL
aly	NULL
wage	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

-	NULL
Changes	NULL
in	NULL
the	NULL
protooncogene	NULL
expression	NULL
of	NULL
c-fos	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
c-myb	NULL
after	NULL
short	NULL
term	NULL
incubation	NULL
of	NULL
U-937	NULL
cells	NULL
with	NULL
5	NULL
x	NULL
107	NULL
``	NULL
m	NULL
TPA	NULL
(	NULL
O-60	NULL
min	NULL
}	NULL
.	NULL

over	NULL
36	NULL
days	NULL
,	NULL
however	NULL
,	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
growth	NULL
of	NULL
a	NULL
nonadherent	NULL
population	NULL
and	NULL
appearance	NULL
of	NULL
a	NULL
phenotype	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
control	NULL
U-937	NULL
cells	NULL
.	NULL

This	NULL
phenomenon	NULL
has	NULL
been	NULL
characterized	NULL
by	NULL
us	NULL
as	NULL
a	NULL
retrodifferentiation	NULL
(	NULL
13	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
documented	NULL
that	NULL
this	NULL
retrodifferentiation	NULL
process	NULL
is	NULL
mediated	NULL
neither	NULL
by	NULL
TPA-resistant	NULL
subclones	NULL
nor	NULL
by	NULL
noninduced	NULL
cell	NULL
artifacts	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
retrodifferentiated	NULL
cells	NULL
regain	NULL
sensitivity	NULL
to	NULL
TPA	NULL
and	NULL
can	NULL
be	NULL
reinduced	NULL
to	NULL
differentiate	NULL
along	NULL
the	NULL
monocytic	NULL
lineage	NULL
.	NULL

Although	NULL
U-937	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TPA	NULL
for	NULL
only	NULL
3	NULL
days	NULL
,	NULL
activation	NULL
of	NULL
PKC	NULL
was	NULL
associated	NULL
with	NULL
prolonged	NULL
incorporation	NULL
of	NULL
PH	NULL
]	NULL
TPA	NULL
.	NULL

However	NULL
,	NULL
when	NULL
the	NULL
PH	NULL
]	NULL
JTPA	NULL
levels	NULL
decreased	NULL
below	NULL
1	NULL
%	NULL
of	NULL
initial	NULL
binding	NULL
,	NULL
the	NULL
cells	NULL
began	NULL
to	NULL
retrodifferentiate	NULL
,	NULL
and	NULL
the	NULL
distribution	NULL
of	NULL
PKC	NULL
returned	NULL
toward	NULL
patterns	NULL
found	NULL
in	NULL
control	NULL
cells	NULL
,	NULL
The	NULL
unaltered	NULL
R	NULL
;	NULL
values	NULL
of	NULL
the	NULL
radioactive	NULL
peaks	NULL
in	NULL
accordance	NULL
with	NULL
a	NULL
[	NULL
°	NULL
'	NULL
H	NULL
]	NULL
TPA	NULL
reference	NULL
suggest	NULL
that	NULL
the	NULL
major	NULL
part	NULL
of	NULL
cell-associated	NULL
TPA	NULL
is	NULL
not	NULL
metabolized	NULL
during	NULL
long	NULL
term	NULL
culture	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
it	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
decreasing	NULL
levels	NULL
of	NULL
cell-associated	NULL
TPA	NULL
are	NULL
not	NULL
only	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
545	NULL
£	NULL
£	NULL
U0	NULL
%	NULL
UV	NULL
UV	NULL
G	NULL
UV	NULL
U	NULL
o	NULL
a	NULL
-	NULL
a	NULL
®	NULL
0	NULL
o	NULL
#	NULL
4	NULL
©	NULL
hast	NULL
-	NULL
®	NULL
®	NULL
28S-	NULL
4	NULL
-	NULL
c-fos	NULL
18s-	NULL
‘	NULL
m	NULL
...	NULL
28S-c-jun	NULL
188—	NULL
ZSS-m	NULL
c-myb	NULL
18Ss-Control	NULL
1885-	NULL
mo	NULL
0	NULL
U0	NULL
@	NULL
#	NULL
#	NULL
w	NULL
an	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Changes	NULL
in	NULL
the	NULL
protooncogene	NULL
expression	NULL
of	NULL
c-fos	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
c-myb	NULL
during	NULL
long	NULL
term	NULL
culture	NULL
of	NULL
TPA-differentiated	NULL
U-937	NULL
cells	NULL
(	NULL
0-36	NULL
days	NULL
)	NULL
.	NULL

due	NULL
to	NULL
lateral	NULL
diffusion	NULL
into	NULL
the	NULL
culture	NULL
supernatant	NULL
,	NULL
since	NULL
the	NULL
retrodifferentiation	NULL
process	NULL
can	NULL
not	NULL
be	NULL
induced	NULL
by	NULL
extensive	NULL
washes	NULL
of	NULL
TPA-treated	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
PKC	NULL
by	NULL
TPA	NULL
results	NULL
in	NULL
its	NULL
translocation	NULL
to	NULL
the	NULL
cell	NULL
membrane	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
is	NULL
usually	NULL
tran-sient	NULL
,	NULL
with	NULL
subsequent	NULL
degradation	NULL
of	NULL
PKC	NULL
into	NULL
regulatory	NULL
and	NULL
catalytic	NULL
subunits	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
in	NULL
this	NULL
study	NULL
indicated	NULL
a	NULL
rapid	NULL
down-regulation	NULL
of	NULL
PKCB	NULL
protein	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
TPA-treated	NULL
U-937	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
PKC	NULL
activation	NULL
was	NULL
also	NULL
detectable	NULL
in	NULL
the	NULL
cell	NULL
membrane	NULL
fraction	NULL
,	NULL
and	NULL
membrane-associated	NULL
PKC	NULL
activity	NULL
per	NULL
cell	NULL
remained	NULL
significantly	NULL
elevated	NULL
at	NULL
5	NULL
days	NULL
.	NULL

This	NULL
membrane-bound	NULL
activity	NULL
persisted	NULL
at	NULL
increased	NULL
levels	NULL
for	NULL
up	NULL
to	NULL
17-29	NULL
days	NULL
.	NULL

Recent	NULL
findings	NULL
,	NULL
which	NULL
support	NULL
our	NULL
results	NULL
,	NULL
have	NULL
demonstrated	NULL
that	NULL
PKCa	NULL
is	NULL
rapidly	NULL
translocated	NULL
in	NULL
TPA-treated	NULL
U-937	NULL
cells	NULL
and	NULL
then	NULL
down-regulated	NULL
after	NULL
3-6	NULL
h.	NULL
At	NULL
this	NULL
time	NULL
,	NULL
membrane-associated	NULL
PKCy	NULL
activity	NULL
is	NULL
increased	NULL
and	NULL
remains	NULL
activated	NULL
for	NULL
over	NULL
24	NULL
h	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Although	NULL
PKC	NULL
is	NULL
known	NULL
to	NULL
consist	NULL
of	NULL
at	NULL
least	NULL
seven	NULL
isoenzymes	NULL
with	NULL
different	NULL
Ca**	NULL
and	NULL
lipid	NULL
affinities	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
,	NULL
the	NULL
present	NULL
work	NULL
has	NULL
distinguished	NULL
between	NULL
the	NULL
different	NULL
expression	NULL
pattern	NULL
of	NULL
PKCa	NULL
,	NULL
PKCB	NULL
,	NULL
and	NULL
PKCy	NULL
mRNA	NULL
transcripts	NULL
during	NULL
long	NULL
term	NULL
culture	NULL
of	NULL
TPA-differentiated	NULL
U-937	NULL
cells	NULL
.	NULL

Temporal	NULL
changes	NULL
in	NULL
distribution	NULL
of	NULL
PKC	NULL
isoenzymes	NULL
have	NULL
been	NULL
reported	NULL
in	NULL
TPA-treated	NULL
HL-60	NULL
cells	NULL
(	NULL
24	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
persistent	NULL
activation	NULL
of	NULL
at	NULL
least	NULL
one	NULL
form	NULL
of	NULL
this	NULL
enzyme	NULL
or	NULL
subsequent	NULL
activation	NULL
of	NULL
several	NULL
different	NULL
PKC	NULL
isoenzymes	NULL
during	NULL
the	NULL
process	NULL
of	NULL
differentiation	NULL
which	NULL
may	NULL
depend	NULL
on	NULL
alterations	NULL
in	NULL
the	NULL
lipid	NULL
composition	NULL
of	NULL
the	NULL
membranes	NULL
.	NULL

This	NULL
is	NULL
also	NULL
supported	NULL
by	NULL
our	NULL
previous	NULL
studies	NULL
which	NULL
demonstrate	NULL
alterations	NULL
in	NULL
the	NULL
membrane	NULL
phospholipid	NULL
composition	NULL
during	NULL
differentiation	NULL
of	NULL
U937	NULL
cells	NULL
(	NULL
25	NULL
)	NULL
.	NULL

TPA	NULL
treatment	NULL
is	NULL
associated	NULL
with	NULL
translocation	NULL
of	NULL
PKC	NULL
and	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
characterized	NULL
by	NULL
(	NULL
a	NULL
)	NULL
growth	NULL
inhibition	NULL
;	NULL
(	NULL
b	NULL
)	NULL
adherence	NULL
;	NULL
(	NULL
c	NULL
)	NULL
changes	NULL
in	NULL
glycosidase	NULL
activity	NULL
;	NULL
(	NULL
d	NULL
)	NULL
cytokine	NULL
release	NULL
;	NULL
and	NULL
(	NULL
e	NULL
)	NULL
increases	NULL
in	NULL
filament	NULL
expression	NULL
.	NULL

These	NULL
changes	NULL
have	NULL
previously	NULL
been	NULL
reported	NULL
with	NULL
appearance	NULL
of	NULL
the	NULL
monocytic	NULL
phenotype	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
U-937	NULL
cell	NULL
differentiation	NULL
was	NULL
associated	NULL
with	NULL
down-regulation	NULL
of	NULL
c-myb	NULL
transcripts	NULL
and	NULL
rapid	NULL
increases	NULL
in	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
.	NULL

Previous	NULL
work	NULL
confirmed	NULL
these	NULL
expression	NULL
patterns	NULL
during	NULL
monocytic	NULL
differentiation	NULL
(	NULL
4-6	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
thus	NULL
indicate	NULL
that	NULL
PKC	NULL
activation	NULL
is	NULL
associated	NULL
with	NULL
specific	NULL
changes	NULL
in	NULL
phenotype	NULL
and	NULL
gene	NULL
expression	NULL
during	NULL
U-937	NULL
monocyctic	NULL
differentiation	NULL
.	NULL

Of	NULL
interest	NULL
,	NULL
the	NULL
persistent	NULL
activation	NULL
of	NULL
PKC	NULL
was	NULL
associated	NULL
with	NULL
prolonged	NULL
expression	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
genes	NULL
.	NULL

With	NULL
respect	NULL
to	NULL
c-jun	NULL
,	NULL
its	NULL
biphasic	NULL
and	NULL
long	NULL
term	NULL
expression	NULL
corresponding	NULL
to	NULL
the	NULL
time	NULL
course	NULL
of	NULL
c-fos	NULL
is	NULL
surprising	NULL
and	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
shown	NULL
.	NULL

Since	NULL
the	NULL
fos	NULL
and	NULL
jun	NULL
proteins	NULL
are	NULL
known	NULL
to	NULL
form	NULL
heterodimers	NULL
with	NULL
leucine	NULL
zipper	NULL
binding	NULL
properties	NULL
(	NULL
AP-1	NULL
)	NULL
(	NULL
26	NULL
)	NULL
,	NULL
the	NULL
present	NULL
data	NULL
Table	NULL
1	NULL
-	NULL
Effect	NULL
of	NULL
staurosporine	NULL
on	NULL
the	NULL
adherence	NULL
and	NULL
viability	NULL
of	NULL
TPA-treated	NULL
U-937	NULL
cells	NULL
U-937	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
24-well	NULL
plates	NULL
at	NULL
a	NULL
density	NULL
of	NULL
5	NULL
®	NULL
10°	NULL
cells/ml	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
or	NULL
without	NULL
different	NULL
concentrations	NULL
of	NULL
staurosporine	NULL
(	NULL
stauro	NULL
)	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Thereafter	NULL
,	NULL
5	NULL
X	NULL
107°	NULL
m	NULL
TPA	NULL
was	NULL
added	NULL
(	NULL
TPA-U-937	NULL
)	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h.	NULL
The	NULL
adherence	NULL
and	NULL
viability	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Data	NULL
represent	NULL
means	NULL
+	NULL
SD	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
.	NULL

Suspension	NULL
Adherence	NULL
Culture	NULL
a	NULL
a	NULL
Cell	NULL
no	NULL
.	NULL

(	NULL
10	NULL
abilito	NULL
(	NULL
0	NULL
Cell	NULL
no	NULL
.	NULL

(	NULL
10	NULL
(	NULL
0	NULL
celis/ml	NULL
)	NULL
Viability	NULL
(	NULL
%	NULL
)	NULL
cells/ml	NULL
)	NULL
Viability	NULL
(	NULL
%	NULL
)	NULL
U-937	NULL
193	NULL
+	NULL
34	NULL
97	NULL
£	NULL
2	NULL
0	NULL
TPA-U-937	NULL
22	NULL
+	NULL
7	NULL
79	NULL
£	NULL
4	NULL
63	NULL
+	NULL
18	NULL
97	NULL
£	NULL
2	NULL
TPA-U-937	NULL
+	NULL
3	NULL
x	NULL
107°	NULL
m	NULL
stauro	NULL
52	NULL
+	NULL
3	NULL
96	NULL
+	NULL
3	NULL
27	NULL
£	NULL
4	NULL
98	NULL
£	NULL
1	NULL
TPA-U-937	NULL
+	NULL
6	NULL
x	NULL
107°	NULL
m	NULL
stauro	NULL
70	NULL
#	NULL
8	NULL
97	NULL
£	NULL
2	NULL
3	NULL
#	NULL
1	NULL
98	NULL
£	NULL
1	NULL
TPA-U-937	NULL
+	NULL
107°	NULL
m	NULL
stauro	NULL
84	NULL
+	NULL
12	NULL
88	NULL
+	NULL
6	NULL
0	NULL
TPA-U-937	NULL
+	NULL
5	NULL
x	NULL
107	NULL
``	NULL
m	NULL
stauro	NULL
53	NULL
+	NULL
9	NULL
25	NULL
+	NULL
8	NULL
0	NULL
546	NULL
-	NULL
PKC	NULL
Activation	NULL
in	NULL
U-937	NULL
Differentiation	NULL
and	NULL
Retrodifferentiation	NULL
Table	NULL
2	NULL
-	NULL
Effect	NULL
of	NULL
staurosporine	NULL
on	NULL
the	NULL
proliferation	NULL
of	NULL
U-937	NULL
and	NULL
TPA-treated	NULL
U-937	NULL
cells	NULL
U-937	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
96-well	NULL
microtiter	NULL
plates	NULL
at	NULL
a	NULL
density	NULL
of	NULL
5	NULL
x	NULL
10°	NULL
cells/ml	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
or	NULL
without	NULL
different	NULL
concentrations	NULL
of	NULL
staurosporine	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Thereafter	NULL
,	NULL
5	NULL
X	NULL
107°	NULL
m	NULL
TPA	NULL
was	NULL
added	NULL
(	NULL
TPA-U-937	NULL
)	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
proliferation	NULL
was	NULL
measured	NULL
by	NULL
[	NULL
'	NULL
H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
,	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
2	NULL
)	NULL
,	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
incorporation	NULL
(	NULL
U-937	NULL
control	NULL
=	NULL
100	NULL
%	NULL
)	NULL
was	NULL
calculated	NULL
.	NULL

Data	NULL
represent	NULL
means	NULL
+	NULL
SD	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
the	NULL
data	NULL
relative	NULL
to	NULL
U-937	NULL
control	NULL
and	NULL
to	NULL
TPA-U-937	NULL
was	NULL
evaluated	NULL
by	NULL
Student	NULL
's	NULL
t	NULL
test	NULL
(	NULL
**	NULL
,	NULL
P	NULL
<	NULL
0.01	NULL
)	NULL
.	NULL

Control	NULL
Staurosporine	NULL
concentration	NULL
3	NULL
x	NULL
107°	NULL
m	NULL
6	NULL
%	NULL
107°	NULL
m	NULL
107°	NULL
m	NULL
5	NULL
x	NULL
107°	NULL
m	NULL
U-937	NULL
100.0	NULL
+	NULL
5.9	NULL
110.3	NULL
+	NULL
8.3	NULL
108.5	NULL
£	NULL
2.1	NULL
86.3	NULL
+	NULL
9.6	NULL
43.5	NULL
+	NULL
5.4**	NULL
TPA-U-937	NULL
12.7	NULL
#	NULL
2.5	NULL
11.2	NULL
#	NULL
1.3	NULL
14.1	NULL
#	NULL
1.3	NULL
30.7	NULL
£	NULL
3.8**	NULL
37.2	NULL
£	NULL
4.1**	NULL
4	NULL
<	NULL
Thus	NULL
,	NULL
although	NULL
other	NULL
regulatory	NULL
pathways	NULL
may	NULL
exist	NULL
,	NULL
a	NULL
a	NULL
c-fos	NULL
and	NULL
c-jun	NULL
expression	NULL
in	NULL
U-937	NULL
cells	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
E-	NULL
C	NULL
regulated	NULL
at	NULL
least	NULL
in	NULL
part	NULL
by	NULL
the	NULL
level	NULL
of	NULL
PKC	NULL
activation	NULL
.	NULL

o	NULL
o	NULL
Indeed	NULL
,	NULL
the	NULL
present	NULL
findings	NULL
also	NULL
demonstrate	NULL
that	NULL
inhi-5	NULL
S	NULL
bition	NULL
of	NULL
PKC	NULL
with	NULL
staurosporine	NULL
greatly	NULL
diminishes	NULL
the	NULL
3	NULL
S	NULL
induction	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
expression	NULL
by	NULL
TPA	NULL
.	NULL

Similar	NULL
D	NULL
_	NULL
®	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
H7	NULL
,	NULL
another	NULL
nonspecific	NULL
PKC	NULL
5	NULL
5s	NULL
inhibitor	NULL
(	NULL
28	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
w	NULL
-	NULL
©	NULL
findings	NULL
support	NULL
the	NULL
role	NULL
of	NULL
PKC	NULL
activation	NULL
in	NULL
the	NULL
control	NULL
m	NULL
0	NULL
o	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
expression	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

M	NULL
_	NULL
<	NULL
m	NULL
-	NULL
In	NULL
conclusion	NULL
,	NULL
the	NULL
rapid	NULL
activation	NULL
of	NULL
PKC	NULL
and	NULL
c-fos/c-g	NULL
a	NULL
”	NULL
_	NULL
a	NULL
jun	NULL
gene	NULL
expression	NULL
are	NULL
very	NULL
early	NULL
events	NULL
after	NULL
phorbol	NULL
,	NULL
ester	NULL
treatment	NULL
of	NULL
U-937	NULL
cells	NULL
followed	NULL
by	NULL
the	NULL
induction	NULL
of	NULL
differentiation-associated	NULL
parameters	NULL
.	NULL

The	NULL
permanent	NULL
28S-	NULL
activation	NULL
of	NULL
PKC	NULL
or	NULL
subsequent	NULL
activation	NULL
of	NULL
PKC	NULL
iso-C	NULL
‘	NULL
fOS	NULL
enzymes	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
high	NULL
level	NULL
of	NULL
the	NULL
protooncogenes	NULL
c-fos	NULL
and	NULL
c-jun	NULL
and	NULL
the	NULL
low	NULL
level	NULL
of	NULL
c-myb	NULL
18S-	NULL
suggests	NULL
a	NULL
crucial	NULL
role	NULL
for	NULL
PKC	NULL
in	NULL
controlling	NULL
both	NULL
the	NULL
arrested	NULL
cell	NULL
growth	NULL
and	NULL
the	NULL
maintenance	NULL
of	NULL
these	NULL
human	NULL
tumor	NULL
cells	NULL
in	NULL
a	NULL
differentiated	NULL
state	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
28S-	NULL
Cell	NULL
Culture	NULL
.	NULL

U-937	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
C—jun	NULL
containing	NULL
5	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
in	NULL
a	NULL
37°C	NULL
.	NULL

.	NULL

humidified	NULL
atmosphere	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

18S-	NULL
The	NULL
induction	NULL
of	NULL
differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
with	NULL
5	NULL
p	NULL
x	NULL
107°m	NULL
TPA	NULL
for	NULL
72	NULL
h	NULL
and	NULL
the	NULL
following	NULL
long	NULL
term	NULL
culture	NULL
in	NULL
medium	NULL
without	NULL
TPA	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
culture	NULL
medium	NULL
of	NULL
the	NULL
adherent	NULL
differentiated	NULL
U-937	NULL
cells	NULL
was	NULL
replaced	NULL
every	NULL
3	NULL
days	NULL
.	NULL

When	NULL
the	NULL
adherent	NULL
cells	NULL
detached	NULL
(	NULL
retrodifferentiation	NULL
)	NULL
,	NULL
they	NULL
were	NULL
collected	NULL
and	NULL
cultured	NULL
as	NULL
described	NULL
for	NULL
un-contrOI	NULL
treated	NULL
U-937	NULL
control	NULL
cells	NULL
.	NULL

188-	NULL
®	NULL
ama	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Inhibition	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
gene	NULL
expression	NULL
by	NULL
15-min	NULL
prein-cubation	NULL
of	NULL
U-937	NULL
cells	NULL
with	NULL
staurosporine	NULL
(	NULL
Stauro	NULL
)	NULL
following	NULL
1-h	NULL
TPA	NULL
treatment	NULL
.	NULL

suggest	NULL
that	NULL
early	NULL
induction	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
genes	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
differentiation	NULL
pathways	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

This	NULL
has	NULL
been	NULL
shown	NULL
recently	NULL
for	NULL
the	NULL
c-jun	NULL
gene	NULL
expression	NULL
in	NULL
differentiating	NULL
P19	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
question	NULL
whether	NULL
the	NULL
down-regulation	NULL
of	NULL
c-jun	NULL
expression	NULL
in	NULL
U-937	NULL
cells	NULL
after	NULL
3	NULL
days	NULL
and	NULL
its	NULL
reinduction	NULL
between	NULL
4-18	NULL
days	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
subsequent	NULL
activation	NULL
of	NULL
protein	NULL
kinases	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
PKC	NULL
isoenzymes	NULL
;	NULL
pp60*~	NULL
kinase	NULL
;	NULL
cyclic	NULL
AMP-dependent	NULL
PK	NULL
)	NULL
and/or	NULL
other	NULL
factors	NULL
remains	NULL
to	NULL
be	NULL
investigated	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
assessed	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
for	NULL
the	NULL
nonadherent	NULL
U-937	NULL
cells	NULL
and	NULL
by	NULL
acridine	NULL
orange	NULL
staining	NULL
of	NULL
the	NULL
adherent	NULL
TPA-differentiated	NULL
cells	NULL
.	NULL

Protein	NULL
Kinase	NULL
C	NULL
Assay	NULL
.	NULL

U-937	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
and	NULL
suspended	NULL
in	NULL
homogenization	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
4-	NULL
(	NULL
2-hydroxyethyl	NULL
)	NULL
-1-piperazineethanesulfonic	NULL
acid	NULL
,	NULL
pH	NULL
7.4-1	NULL
mm	NULL
ethyleneglycol	NULL
bis	NULL
(	NULL
G-aminoethyl	NULL
ether	NULL
)	NULL
-N	NULL
,	NULL
N	NULL
,	NULL
N	NULL
'	NULL
,	NULL
N	NULL
'	NULL
-tetraacetic	NULL
acid-1	NULL
mm	NULL
EDTA-5	NULL
mm	NULL
2,3-dihydroxybutane-1,4-dithiol	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
homogenized	NULL
by	NULL
sonication	NULL
for	NULL
3	NULL
X	NULL
10	NULL
s	NULL
at	NULL
50	NULL
W	NULL
;	NULL
Labsonic	NULL
cell	NULL
disrupter	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
homogenate	NULL
was	NULL
centrifuged	NULL
at	NULL
3,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
to	NULL
remove	NULL
the	NULL
nuclei	NULL
.	NULL

The	NULL
crude	NULL
membranes	NULL
and	NULL
cytosol	NULL
were	NULL
separated	NULL
by	NULL
centrifugation	NULL
at	NULL
100,000	NULL
x	NULL
g	NULL
for	NULL
30	NULL
min	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
supernatant	NULL
was	NULL
used	NULL
as	NULL
cytosolic	NULL
fraction	NULL
.	NULL

The	NULL
pellet	NULL
was	NULL
resus-pended	NULL
and	NULL
solubilized	NULL
for	NULL
30	NULL
min	NULL
in	NULL
homogenization	NULL
buffer	NULL
containing	NULL
5	NULL
mm	NULL
3	NULL
{	NULL
[	NULL
(	NULL
3-cholamidopropyl	NULL
)	NULL
di-methylamino	NULL
]	NULL
-1-propanesulfonate	NULL
.	NULL

The	NULL
solubilized	NULL
membrane	NULL
fraction	NULL
was	NULL
prepared	NULL
by	NULL
centrifugation	NULL
at	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
547	NULL
100,000	NULL
x	NULL
g	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Aliquots	NULL
containing	NULL
10	NULL
ug	NULL
of	NULL
protein	NULL
were	NULL
used	NULL
to	NULL
measure	NULL
PKC	NULL
activity	NULL
,	NULL
as	NULL
described	NULL
with	NULL
certain	NULL
modifications	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
phosphoryl-ation	NULL
of	NULL
H1	NULL
histone	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
1	NULL
ug	NULL
of	NULL
1,2-dioleoyl-sn-glycerol	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
phosphatidylser-ine	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
200	NULL
ul	NULL
.	NULL

The	NULL
reaction	NULL
medium	NULL
(	NULL
100	NULL
ul	NULL
)	NULL
[	NULL
40	NULL
mm	NULL
4-	NULL
(	NULL
2-hydroxyethyl	NULL
)	NULL
-1-piperazineethanesulfonic	NULL
acid	NULL
,	NULL
pH	NULL
7.4-0.4	NULL
mm	NULL
ethyleneglycol	NULL
bis	NULL
(	NULL
#	NULL
-aminoethyl	NULL
ether	NULL
)	NULL
-N	NULL
,	NULL
N	NULL
,	NULL
N	NULL
'	NULL
,	NULL
N	NULL
'	NULL
-tetraacetic	NULL
acid-1	NULL
mm	NULL
CaCl	NULL
;	NULL
-10	NULL
mm	NULL
MgCl	NULL
;	NULL
-40	NULL
ug	NULL
of	NULL
histone-6	NULL
nmol	NULL
of	NULL
[	NULL
y-*P	NULL
]	NULL
-ATP	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
cpm/nmol	NULL
)	NULL
]	NULL
was	NULL
added	NULL
to	NULL
100	NULL
ul	NULL
of	NULL
protein-containing	NULL
homogenization	NULL
buffer	NULL
with	NULL
or	NULL
without	NULL
lipids	NULL
(	NULL
dispersed	NULL
by	NULL
sonication	NULL
for	NULL
3	NULL
X	NULL
10	NULL
s	NULL
at	NULL
50	NULL
W	NULL
)	NULL
and	NULL
was	NULL
incubated	NULL
for	NULL
3	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
incubation	NULL
was	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
200	NULL
al	NULL
of	NULL
chilled	NULL
trichloroacetic	NULL
acid	NULL
(	NULL
10	NULL
%	NULL
w/v	NULL
)	NULL
containing	NULL
1	NULL
mm	NULL
ATP	NULL
and	NULL
15	NULL
mm	NULL
The	NULL
mixture	NULL
containing	NULL
the	NULL
precipitated	NULL
proteins	NULL
was	NULL
applied	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
,	NULL
and	NULL
the	NULL
radioactivity	NULL
was	NULL
determined	NULL
by	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

PKC	NULL
Western	NULL
Blot	NULL
Analysis	NULL
.	NULL

Cytosol	NULL
and	NULL
the	NULL
crude	NULL
membrane	NULL
fraction	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
for	NULL
the	NULL
PKC	NULL
assay	NULL
.	NULL

Up	NULL
to	NULL
100	NULL
ug	NULL
of	NULL
protein	NULL
were	NULL
separated	NULL
in	NULL
a	NULL
7.5	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
an	NULL
Im-mobilon-P	NULL
membrane	NULL
as	NULL
described	NULL
(	NULL
13	NULL
)	NULL
.	NULL

After	NULL
blocking	NULL
nonspecific	NULL
binding	NULL
sites	NULL
with	NULL
5	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
bovine	NULL
serum	NULL
albumin	NULL
in	NULL
PBS	NULL
for	NULL
1	NULL
h	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
incubated	NULL
for	NULL
12	NULL
h	NULL
with	NULL
the	NULL
monoclonal	NULL
antibodies	NULL
MC-1a	NULL
,	NULL
MC-2a	NULL
,	NULL
and	NULL
MC-3a	NULL
diluted	NULL
to	NULL
1	NULL
ug/ml	NULL
in	NULL
0.25	NULL
%	NULL
bovine	NULL
serum	NULL
albu-min-0.05	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
pH	NULL
8.0	NULL
.	NULL

These	NULL
monoclonal	NULL
antibodies	NULL
were	NULL
prepared	NULL
against	NULL
PKC	NULL
isoenzymes	NULL
PKCa	NULL
,	NULL
PKC	NULL
#	NULL
8	NULL
,	NULL
and	NULL
PKCy	NULL
,	NULL
respectively	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Following	NULL
a	NULL
2-h	NULL
incubation	NULL
with	NULL
'	NULL
``	NULL
l-labeled	NULL
rabbit	NULL
anti-mouse	NULL
antibody	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
washed	NULL
six	NULL
to	NULL
eight	NULL
times	NULL
with	NULL
PBS	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
X-ray	NULL
film	NULL
.	NULL

Incorporation	NULL
of	NULL
TPA	NULL
.	NULL

U-937	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
xX	NULL
10~	NULL
'	NULL
m	NULL
PH	NULL
]	NULL
TPA	NULL
(	NULL
NEN	NULL
)	NULL
for	NULL
72	NULL
h	NULL
and	NULL
then	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TPA	NULL
for	NULL
24	NULL
days	NULL
by	NULL
replacing	NULL
fresh	NULL
medium	NULL
every	NULL
3	NULL
days	NULL
.	NULL

The	NULL
cells	NULL
(	NULL
10°	NULL
)	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
lipid	NULL
extraction	NULL
was	NULL
performed	NULL
by	NULL
chloroform/methanol	NULL
(	NULL
2/1	NULL
,	NULL
v/v	NULL
)	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
samples	NULL
,	NULL
including	NULL
a	NULL
standard	NULL
on	NULL
a	NULL
reference	NULL
lane	NULL
,	NULL
were	NULL
separated	NULL
by	NULL
thin	NULL
layer	NULL
chromatography	NULL
using	NULL
methylene	NULL
chloride/acetone	NULL
(	NULL
3/1	NULL
,	NULL
v/v	NULL
)	NULL
as	NULL
solvent	NULL
system	NULL
.	NULL

The	NULL
thin	NULL
layer	NULL
chromatography	NULL
plates	NULL
were	NULL
cut	NULL
according	NULL
to	NULL
the	NULL
R	NULL
,	NULL
;	NULL
values	NULL
ranging	NULL
from	NULL
0.1	NULL
to	NULL
1.0	NULL
,	NULL
and	NULL
radioactivity	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
B-scintillation	NULL
counter	NULL
.	NULL

Glycosidase	NULL
Activities	NULL
.	NULL

Approximately	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
and	NULL
homogenized	NULL
by	NULL
sonication	NULL
(	NULL
for	NULL
3	NULL
x	NULL
10	NULL
s	NULL
at	NULL
50	NULL
W	NULL
)	NULL
(	NULL
Labsonic	NULL
cell	NULL
disrupter	NULL
;	NULL
Braun	NULL
AG	NULL
,	NULL
Melsungen	NULL
,	NULL
Federal	NULL
Republic	NULL
of	NULL
Germany	NULL
)	NULL
.	NULL

Specific	NULL
activities	NULL
of	NULL
B-galactosidase	NULL
and	NULL
a-mannosidase	NULL
were	NULL
measured	NULL
in	NULL
the	NULL
cell	NULL
homogenate	NULL
by	NULL
the	NULL
capacity	NULL
to	NULL
cleave	NULL
the	NULL
appropriate	NULL
p-nitrophenyl	NULL
sugar	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
measured	NULL
by	NULL
microtiter	NULL
Bradford	NULL
protein	NULL
assay	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Release	NULL
of	NULL
Cytokines	NULL
.	NULL

Cytokine	NULL
release	NULL
into	NULL
the	NULL
culture	NULL
supernatant	NULL
was	NULL
measured	NULL
for	NULL
TNF-a	NULL
and	NULL
IL-18	NULL
using	NULL
specific	NULL
radioimmunoassays	NULL
for	NULL
these	NULL
cytokines	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

TNF-a	NULL
and	NULL
IL-18	NULL
activities	NULL
were	NULL
also	NULL
evaluated	NULL
in	NULL
the	NULL
appropriate	NULL
biological	NULL
assay	NULL
systems	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
from	NULL
untreated	NULL
and	NULL
TPA-differentiated	NULL
U-937	NULL
cells	NULL
was	NULL
prepared	NULL
according	NULL
to	NULL
Chirgwin	NULL
et	NULL
al	NULL
.	NULL

(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
RNA	NULL
pellets	NULL
were	NULL
solubilized	NULL
in	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
the	NULL
purity	NULL
and	NULL
concentration	NULL
of	NULL
the	NULL
RNA	NULL
were	NULL
determined	NULL
by	NULL
absorb-ance	NULL
measurements	NULL
at	NULL
260	NULL
and	NULL
280	NULL
nm	NULL
.	NULL

Aliquots	NULL
of	NULL
20	NULL
ug	NULL
of	NULL
RNA	NULL
were	NULL
separated	NULL
in	NULL
agarose-formaldehyde	NULL
gels	NULL
according	NULL
to	NULL
Lehrach	NULL
et	NULL
al	NULL
.	NULL

(	NULL
38	NULL
)	NULL
.	NULL

After	NULL
electrophoresis	NULL
,	NULL
the	NULL
RNA	NULL
was	NULL
transferred	NULL
to	NULL
Hybond	NULL
N	NULL
nylon	NULL
membranes	NULL
(	NULL
Amersham	NULL
)	NULL
by	NULL
capillary	NULL
blotting	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
hybridized	NULL
at	NULL
42°C	NULL
for	NULL
12	NULL
h	NULL
in	NULL
50	NULL
%	NULL
formamide-1	NULL
%	NULL
SDS-10	NULL
%	NULL
dextran	NULL
sulfate-1	NULL
m	NULL
NaCl	NULL
using	NULL
the	NULL
following	NULL
random	NULL
primer	NULL
[	NULL
P	NULL
]	NULL
dCTP	NULL
labeled	NULL
human	NULL
cDNA	NULL
probes	NULL
:	NULL
(	NULL
a	NULL
)	NULL
a	NULL
1.3-kb	NULL
EcoRl	NULL
PKCa	NULL
insert	NULL
of	NULL
a	NULL
phPKC-a7	NULL
plasmid	NULL
;	NULL
(	NULL
b	NULL
)	NULL
a	NULL
1.8-kb	NULL
EcoRI	NULL
PKC	NULL
insert	NULL
of	NULL
a	NULL
phPKC-81-15-Eco	NULL
plasmid	NULL
;	NULL
(	NULL
c	NULL
)	NULL
a	NULL
1.4-kb	NULL
EcoRl	NULL
PKCy	NULL
insert	NULL
of	NULL
a	NULL
phPKC-y6	NULL
plasmid	NULL
(	NULL
all	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
;	NULL
(	NULL
d	NULL
)	NULL
a	NULL
1.8-kb	NULL
BamHlI/EcoRl	NULL
insert	NULL
of	NULL
a	NULL
human	NULL
c-jun	NULL
DNA	NULL
probe	NULL
containing	NULL
a	NULL
1.0-kb	NULL
cONA	NULL
and	NULL
0.8-kb	NULL
3'-untranslated	NULL
sequences	NULL
(	NULL
40	NULL
)	NULL
purified	NULL
from	NULL
a	NULL
pBluescript	NULL
Sk	NULL
(	NULL
+	NULL
)	NULL
plasmid	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
R.	NULL
Tjian	NULL
)	NULL
;	NULL
(	NULL
e	NULL
)	NULL
a	NULL
3.1-kb	NULL
Xhol/Ncol	NULL
c-fos	NULL
insert	NULL
of	NULL
the	NULL
pc-fos-1	NULL
plasmid	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
c-myb	NULL
cDNA	NULL
and	NULL
the	NULL
185	NULL
control	NULL
cDNA	NULL
probes	NULL
were	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Dr.	NULL
J.	NULL
Schlehofer	NULL
,	NULL
German	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
Heidelberg	NULL
,	NULL
Federal	NULL
Republic	NULL
of	NULL
Germany	NULL
,	NULL
and	NULL
Dr.	NULL
M.	NULL
Revel	NULL
,	NULL
Weizmann	NULL
Institute	NULL
,	NULL
Rehovot	NULL
,	NULL
Israel	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
for	NULL
15	NULL
min	NULL
at	NULL
42°C	NULL
in	NULL
2	NULL
%	NULL
saline-sodium	NULL
phosphate-EDTA	NULL
containing	NULL
1	NULL
%	NULL
SDS	NULL
and	NULL
an	NULL
additional	NULL
four	NULL
times	NULL
in	NULL
0.1	NULL
%	NULL
saline-sodium	NULL
phosphate-EDTA	NULL
containing	NULL
0.1	NULL
%	NULL
SDS	NULL
.	NULL

Thereafter	NULL
,	NULL
the	NULL
filters	NULL
were	NULL
exposed	NULL
at	NULL
-80°C	NULL
for	NULL
12-24	NULL
h.	NULL
For	NULL
vimentin	NULL
and	NULL
lamin	NULL
A/C	NULL
mRNA	NULL
analysis	NULL
,	NULL
labeling	NULL
of	NULL
the	NULL
appropriate	NULL
probes	NULL
and	NULL
hybridization	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Signal	NULL
intensity	NULL
was	NULL
evaluated	NULL
by	NULL
laser	NULL
densitometric	NULL
analysis	NULL
(	NULL
UltroScan	NULL
;	NULL
LKB	NULL
,	NULL
Brommer	NULL
,	NULL
Sweden	NULL
)	NULL
and	NULL
compared	NULL
to	NULL
that	NULL
for	NULL
control	NULL
U-937	NULL
cells	NULL
.	NULL

Acknowledgments	NULL
The	NULL
authors	NULL
thank	NULL
Karin	NULL
Molitor	NULL
and	NULL
Solveig	NULL
Eikemeier	NULL
for	NULL
their	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Lotem	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Sachs	NULL
,	NULL
L.	NULL
Regulation	NULL
of	NULL
normal	NULL
differentiation	NULL
in	NULL
mouse	NULL
and	NULL
human	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
by	NULL
phorbol	NULL
esters	NULL
and	NULL
the	NULL
mechanism	NULL
of	NULL
tumor	NULL
promotion	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
,	NULL
USA	NULL
,	NULL
76	NULL
:	NULL
5158-5162	NULL
,	NULL
1979	NULL
.	NULL

2	NULL
.	NULL

Hass	NULL
,	NULL
R.	NULL
,	NULL
Bartels	NULL
,	NULL
H.	NULL
,	NULL
Topley	NULL
,	NULL
N.	NULL
,	NULL
Hadam	NULL
,	NULL
M.	NULL
,	NULL
Kohler	NULL
,	NULL
L.	NULL
,	NULL
Goppelt-Striibe	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Resch	NULL
,	NULL
K.	NULL
TPA-induced	NULL
differentiation	NULL
and	NULL
adhesion	NULL
of	NULL
U-937	NULL
cells	NULL
:	NULL
changes	NULL
in	NULL
ultrastructure	NULL
,	NULL
cytoskeletal	NULL
organization	NULL
and	NULL
expression	NULL
of	NULL
cell	NULL
surface	NULL
antigens	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
48	NULL
:	NULL
282-293	NULL
,	NULL
1989	NULL
.	NULL

3	NULL
.	NULL

Harris	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Ralph	NULL
,	NULL
P.	NULL
Human	NULL
leukemic	NULL
models	NULL
of	NULL
myelomonocytic	NULL
development	NULL
:	NULL
a	NULL
review	NULL
of	NULL
the	NULL
HL-60	NULL
and	NULL
U-937	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

,	NULL
37	NULL
:	NULL
407-422	NULL
,	NULL
1985	NULL
.	NULL

4	NULL
.	NULL

Mitchell	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Zokas	NULL
,	NULL
L.	NULL
,	NULL
Schreiber	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
Rapid	NULL
induction	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
proto-oncogene	NULL
fos	NULL
during	NULL
human	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Cell	NULL
,	NULL
40	NULL
:	NULL
209-217	NULL
,	NULL
1985	NULL
.	NULL

5	NULL
.	NULL

Miller	NULL
,	NULL
R.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
Miller	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Guilbert	NULL
,	NULL
L.	NULL
Induction	NULL
of	NULL
c-fos	NULL
during	NULL
myelomonocytic	NULL
differentiation	NULL
and	NULL
macrophage	NULL
proliferation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
314	NULL
:	NULL
546-548	NULL
,	NULL
1985	NULL
.	NULL

6	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Stone	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Datta	NULL
,	NULL
R.	NULL
,	NULL
Bernstein	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
Transcriptional	NULL
and	NULL
posttranscriptional	NULL
regulation	NULL
of	NULL
c-jun	NULL
expression	NULL
during	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
265	NULL
:	NULL
3320-3323	NULL
,	NULL
1990	NULL
.	NULL

7	NULL
.	NULL

Sariban	NULL
,	NULL
E.	NULL
,	NULL
Mitchell	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
Expression	NULL
of	NULL
the	NULL
c-fms	NULL
protooncogene	NULL
during	NULL
human	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
316	NULL
:	NULL
64-66	NULL
,	NULL
1985	NULL
.	NULL

8	NULL
.	NULL

Horiguchi	NULL
,	NULL
J.	NULL
,	NULL
Spriggs	NULL
,	NULL
D.	NULL
,	NULL
Imamura	NULL
,	NULL
K.	NULL
,	NULL
Stone	NULL
,	NULL
R.	NULL
,	NULL
Luebbers	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
Role	NULL
of	NULL
arachidonic	NULL
acid	NULL
metabolism	NULL
in	NULL
the	NULL
transcriptional	NULL
induction	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
gene	NULL
expression	NULL
by	NULL
phorbol	NULL
ester	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
9	NULL
:	NULL
252-258	NULL
,	NULL
1989	NULL
.	NULL

9	NULL
.	NULL

Ashendel	NULL
,	NULL
C.	NULL
L.	NULL
The	NULL
phorbol	NULL
ester	NULL
receptor	NULL
:	NULL
a	NULL
phospholipid-regulated	NULL
protein	NULL
kinase	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
822	NULL
:	NULL
219-242	NULL
,	NULL
1985	NULL
.	NULL

548	NULL
-	NULL
PKC	NULL
Activation	NULL
in	NULL
U-937	NULL
Differentiation	NULL
and	NULL
Retrodifferentiation	NULL
10	NULL
.	NULL

Nishizuka	NULL
,	NULL
Y	NULL
.	NULL

The	NULL
role	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
cell	NULL
surface	NULL
signal	NULL
transduction	NULL
and	NULL
tumour	NULL
promotion	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
308	NULL
:	NULL
693-697	NULL
,	NULL
1984	NULL
.	NULL

11	NULL
.	NULL

Ebeling	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Vandenbark	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Kuhn	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Ganong	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Bell	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Niedel	NULL
,	NULL
J.	NULL
E.	NULL
Diacylglycerols	NULL
mimic	NULL
phorbol	NULL
diester	NULL
induction	NULL
of	NULL
leukemic	NULL
cell	NULL
differentiation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
82	NULL
:	NULL
815-819	NULL
,	NULL
1985	NULL
.	NULL

12	NULL
.	NULL

Hannum	NULL
,	NULL
Y	NULL
.	NULL

A.	NULL
,	NULL
Loomis	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Merrill	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Bell	NULL
,	NULL
R.	NULL
M.	NULL
Sphingosine	NULL
inhibition	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
activity	NULL
and	NULL
of	NULL
phorbol	NULL
dibu-tyrate	NULL
binding	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
human	NULL
platelets	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
261	NULL
:	NULL
12604~	NULL
12609	NULL
,	NULL
1986	NULL
.	NULL

13	NULL
.	NULL

Hass	NULL
,	NULL
R.	NULL
,	NULL
Giese	NULL
,	NULL
G.	NULL
,	NULL
Meyer	NULL
,	NULL
G.	NULL
,	NULL
Hartmann	NULL
,	NULL
A.	NULL
,	NULL
Dork	NULL
,	NULL
T.	NULL
,	NULL
Kohler	NULL
,	NULL
L.	NULL
,	NULL
Resch	NULL
,	NULL
K.	NULL
,	NULL
Traub	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Goppelt-Stribe	NULL
,	NULL
M.	NULL
Differentiation	NULL
and	NULL
retrodifferentiation	NULL
of	NULL
U937	NULL
cells	NULL
:	NULL
reversible	NULL
induction	NULL
and	NULL
suppression	NULL
of	NULL
intermediate	NULL
filament	NULL
protein	NULL
synthesis	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
51	NULL
:	NULL
265-271	NULL
,	NULL
1990	NULL
.	NULL

14	NULL
.	NULL

Hass	NULL
,	NULL
R.	NULL
,	NULL
Kohler	NULL
,	NULL
L.	NULL
,	NULL
Rehfeldt	NULL
,	NULL
W.	NULL
,	NULL
Lessmann	NULL
,	NULL
V.	NULL
,	NULL
Miller	NULL
,	NULL
W.	NULL
,	NULL
Resch	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Goppelt-Strube	NULL
,	NULL
M.	NULL
Alterations	NULL
in	NULL
glycosylation	NULL
and	NULL
lectin	NULL
pattern	NULL
during	NULL
phorbol	NULL
ester-induced	NULL
differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
50	NULL
:	NULL
323-327	NULL
,	NULL
1990	NULL
.	NULL

15	NULL
.	NULL

Tamaoki	NULL
,	NULL
T.	NULL
,	NULL
Nomoto	NULL
,	NULL
H.	NULL
,	NULL
Takahashi	NULL
,	NULL
I.	NULL
,	NULL
Kato	NULL
,	NULL
H.	NULL
,	NULL
Morimoto	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Tomita	NULL
,	NULL
F.	NULL
Staurosporine	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
phospholipid/Ca®*	NULL
dependent	NULL
protein	NULL
kinase	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
135	NULL
:	NULL
397-402	NULL
,	NULL
1986	NULL
.	NULL

16	NULL
.	NULL

Barendsen	NULL
,	NULL
N.	NULL
,	NULL
Mueller	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Chen	NULL
,	NULL
B.	NULL
Inhibition	NULL
of	NULL
TPA-induced	NULL
monocytic	NULL
differentiation	NULL
in	NULL
THP-1	NULL
human	NULL
monocytic	NULL
leukemic	NULL
cells	NULL
by	NULL
staurosporine	NULL
,	NULL
a	NULL
potent	NULL
protein	NULL
kinase	NULL
C	NULL
inhibitor	NULL
.	NULL

Leuk	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
14	NULL
:	NULL
467-474	NULL
,	NULL
1990	NULL
.	NULL

17	NULL
.	NULL

Kraft	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
and	NULL
Andersen	NULL
,	NULL
W.	NULL
B.	NULL
Phorbol	NULL
esters	NULL
increase	NULL
the	NULL
amount	NULL
of	NULL
Ca®*	NULL
,	NULL
phospholipid-dependent	NULL
protein	NULL
kinase	NULL
associated	NULL
with	NULL
plasma	NULL
membrane	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
301	NULL
:	NULL
621-623	NULL
,	NULL
1983	NULL
.	NULL

18	NULL
.	NULL

Wolf	NULL
,	NULL
M.	NULL
,	NULL
LeVine	NULL
,	NULL
H.	NULL
,	NULL
III	NULL
,	NULL
May	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Jr.	NULL
,	NULL
Cuatrecasas	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sahyoun	NULL
,	NULL
N.	NULL
A	NULL
model	NULL
for	NULL
intracellular	NULL
translocation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
involving	NULL
synergism	NULL
between	NULL
Ca	NULL
``	NULL
*	NULL
and	NULL
phorbol	NULL
esters	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
317	NULL
:	NULL
546-549	NULL
,	NULL
1985	NULL
.	NULL

19	NULL
.	NULL

Fournier	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Murray	NULL
,	NULL
A.	NULL
W.	NULL
Application	NULL
of	NULL
phorbol	NULL
ester	NULL
to	NULL
mouse	NULL
skin	NULL
causes	NULL
a	NULL
rapid	NULL
and	NULL
sustained	NULL
loss	NULL
of	NULL
protein	NULL
kinase	NULL
C.	NULL
Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
330	NULL
:	NULL
767-769	NULL
,	NULL
1987	NULL
.	NULL

20	NULL
.	NULL

Young	NULL
,	NULL
S.	NULL
,	NULL
Parker	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Stabel	NULL
,	NULL
S.	NULL
Down-regulation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
is	NULL
due	NULL
to	NULL
an	NULL
increased	NULL
rate	NULL
of	NULL
degradation	NULL
.	NULL

Biochem	NULL
.	NULL

J.	NULL
,	NULL
244	NULL
:	NULL
775-779	NULL
,	NULL
1987	NULL
.	NULL

21	NULL
.	NULL

Strulovici	NULL
,	NULL
B.	NULL
,	NULL
Daniel-Issakani	NULL
,	NULL
S.	NULL
,	NULL
Oto	NULL
,	NULL
E.	NULL
,	NULL
Nestor	NULL
,	NULL
J.	NULL
,	NULL
Jr.	NULL
,	NULL
Chan	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Tsou	NULL
,	NULL
A.	NULL
P.	NULL
Activation	NULL
of	NULL
distinct	NULL
protein	NULL
kinase	NULL
C	NULL
isoenzymes	NULL
by	NULL
phorbol	NULL
esters	NULL
:	NULL
correlation	NULL
with	NULL
induction	NULL
of	NULL
interleukin-18	NULL
gene	NULL
expression	NULL
.	NULL

Biochemistry	NULL
,	NULL
28	NULL
:	NULL
3569-3576	NULL
,	NULL
1989	NULL
.	NULL

22	NULL
.	NULL

Nishizuka	NULL
,	NULL
Y	NULL
.	NULL

The	NULL
molecular	NULL
heterogeneity	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
its	NULL
implications	NULL
for	NULL
cellular	NULL
regulation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
334	NULL
:	NULL
661-665	NULL
,	NULL
1988	NULL
.	NULL

23	NULL
.	NULL

Koretzky	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
Wahi	NULL
,	NULL
M.	NULL
,	NULL
Newton	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

Heterogeneity	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
isoenzyme	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
143	NULL
:	NULL
1692-1695	NULL
,	NULL
1989	NULL
.	NULL

24	NULL
.	NULL

Kiss	NULL
,	NULL
Z.	NULL
,	NULL
Deli	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Kuo	NULL
,	NULL
J.	NULL
F.	NULL
Temporal	NULL
changes	NULL
in	NULL
intracellular	NULL
distribution	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
during	NULL
differentiation	NULL
of	NULL
human	NULL
leukemia	NULL
HL-60	NULL
cells	NULL
induced	NULL
by	NULL
phorbol	NULL
ester	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

,	NULL
231	NULL
:	NULL
41-46	NULL
,	NULL
1988	NULL
.	NULL

25	NULL
.	NULL

Koehler	NULL
,	NULL
L.	NULL
,	NULL
Hass	NULL
,	NULL
R.	NULL
,	NULL
Wessel	NULL
,	NULL
K.	NULL
,	NULL
DeWitt	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Kaever	NULL
,	NULL
V.	NULL
,	NULL
Resch	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Goppelt-Striibe	NULL
,	NULL
M.	NULL
Altered	NULL
arachidonic	NULL
acid	NULL
metabolism	NULL
during	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
monoblastoid	NULL
cell	NULL
line	NULL
U937	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1042	NULL
:	NULL
395-403	NULL
,	NULL
1990	NULL
.	NULL

26	NULL
.	NULL

Abel	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
Action	NULL
of	NULL
leucine	NULL
zippers	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
341	NULL
:	NULL
24-25	NULL
,	NULL
1989	NULL
.	NULL

27.	NULL
de	NULL
Groot	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Kruyt	NULL
,	NULL
F.	NULL
A.	NULL
E.	NULL
,	NULL
van	NULL
der	NULL
Saag	NULL
,	NULL
P.	NULL
T.	NULL
,	NULL
and	NULL
Kruijer	NULL
,	NULL
W.	NULL
Ectopic	NULL
expression	NULL
of	NULL
c-jun	NULL
leads	NULL
to	NULL
differentiation	NULL
of	NULL
P19	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
9	NULL
:	NULL
1831-1837	NULL
,	NULL
1990	NULL
.	NULL

28	NULL
.	NULL

Hidaka	NULL
,	NULL
H.	NULL
,	NULL
Inagaki	NULL
,	NULL
M.	NULL
,	NULL
Kawamoto	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Sasaki	NULL
,	NULL
Y.	NULL
isoquinoline-sulfonamides	NULL
,	NULL
novel	NULL
and	NULL
potent	NULL
inhibitors	NULL
of	NULL
cyclic	NULL
nucleotide	NULL
dependent	NULL
protein	NULL
kinase	NULL
and	NULL
protein	NULL
kinase	NULL
C.	NULL
Biochemistry	NULL
,	NULL
23	NULL
:	NULL
5036-5041	NULL
,	NULL
1984	NULL
.	NULL

29	NULL
.	NULL

Pfannkuche	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Kaever	NULL
,	NULL
V.	NULL
,	NULL
Gemsa	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Resch	NULL
,	NULL
K.	NULL
Regulation	NULL
of	NULL
prostaglandin	NULL
synthesis	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
mouse	NULL
peritoneal	NULL
macrophages	NULL
.	NULL

Biochem	NULL
.	NULL

J.	NULL
,	NULL
260	NULL
:	NULL
471-478	NULL
,	NULL
1989	NULL
.	NULL

30	NULL
.	NULL

Hidaka	NULL
,	NULL
H.	NULL
,	NULL
Tanaka	NULL
,	NULL
T.	NULL
,	NULL
Onoda	NULL
,	NULL
K.	NULL
,	NULL
Hagiwara	NULL
,	NULL
M.	NULL
,	NULL
Watanabe	NULL
,	NULL
M.	NULL
,	NULL
Ohta	NULL
,	NULL
H.	NULL
,	NULL
Ito	NULL
,	NULL
Y.	NULL
,	NULL
Tsurudome	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Yoshida	NULL
,	NULL
T.	NULL
Cell	NULL
type-specific	NULL
expression	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
isoenzymes	NULL
in	NULL
the	NULL
rabbit	NULL
cerebellum	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
263	NULL
:	NULL
4523-4526	NULL
,	NULL
1988	NULL
.	NULL

31	NULL
.	NULL

Goppelt	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Resch	NULL
,	NULL
K.	NULL
Densitometric	NULL
quantitation	NULL
of	NULL
individual	NULL
phospholipids	NULL
from	NULL
natural	NULL
sources	NULL
separated	NULL
by	NULL
one-dimensional	NULL
thin-layer	NULL
chromatography	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
140	NULL
:	NULL
152-156	NULL
,	NULL
1984	NULL
.	NULL

32	NULL
.	NULL

Gatt	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Rapport	NULL
,	NULL
M.	NULL
M.	NULL
Isolation	NULL
of	NULL
-galactosidase	NULL
and	NULL
$	NULL
-glucosidase	NULL
from	NULL
brain	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
113	NULL
:	NULL
567-576	NULL
,	NULL
1966	NULL
.	NULL

33	NULL
.	NULL

Redinbaugh	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
Campbell	NULL
,	NULL
W.	NULL
H.	NULL
Adaptation	NULL
of	NULL
the	NULL
dye-binding	NULL
protein	NULL
assay	NULL
to	NULL
microtiter	NULL
plates	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
147	NULL
:	NULL
144-147	NULL
,	NULL
1985	NULL
.	NULL

34	NULL
.	NULL

Lisi	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Chu	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
Koch	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
Endres	NULL
,	NULL
S.	NULL
,	NULL
Lonnemann	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Dinarello	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

Development	NULL
and	NULL
use	NULL
of	NULL
a	NULL
radioimmunoassay	NULL
for	NULL
human	NULL
interleukin-18	NULL
.	NULL

Lymphokine	NULL
Res	NULL
.	NULL

,	NULL
6	NULL
:	NULL
229-244	NULL
,	NULL
1987	NULL
.	NULL

35.	NULL
van	NULL
den	NULL
Meer	NULL
,	NULL
J.	NULL
H.	NULL
W.	NULL
,	NULL
Endres	NULL
,	NULL
S.	NULL
,	NULL
Lonneman	NULL
,	NULL
G.	NULL
,	NULL
Cannon	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Ikejima	NULL
,	NULL
T.	NULL
,	NULL
Okusawa	NULL
,	NULL
S.	NULL
,	NULL
Gelfand	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Dinarello	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

Concentrations	NULL
of	NULL
immunoreactive	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
produced	NULL
by	NULL
human	NULL
mononuclear	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

,	NULL
43	NULL
:	NULL
216-223	NULL
,	NULL
1988	NULL
.	NULL

36	NULL
.	NULL

Hass	NULL
,	NULL
R.	NULL
,	NULL
Lonnemann	NULL
,	NULL
G.	NULL
,	NULL
Mannel	NULL
,	NULL
D.	NULL
,	NULL
Topley	NULL
,	NULL
N.	NULL
,	NULL
Hartmann	NULL
,	NULL
A.	NULL
,	NULL
Kohler	NULL
,	NULL
L.	NULL
,	NULL
Resch	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Goppelt-Stribe	NULL
,	NULL
M.	NULL
Regulation	NULL
of	NULL
TNF-a	NULL
,	NULL
IL-1	NULL
and	NULL
IL-6	NULL
synthesis	NULL
in	NULL
differentiating	NULL
human	NULL
monoblastoid	NULL
leukemic	NULL
UQ37	NULL
cells	NULL
.	NULL

Leuk	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
15	NULL
:	NULL
327-339	NULL
,	NULL
1991	NULL
.	NULL

37	NULL
.	NULL

Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribonuclease	NULL
.	NULL

Biochemistry	NULL
,	NULL
18	NULL
:	NULL
5294-5299	NULL
,	NULL
1979	NULL
.	NULL

38	NULL
.	NULL

Lehrach	NULL
,	NULL
H.	NULL
,	NULL
Diamond	NULL
,	NULL
D.	NULL
,	NULL
Wozney	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Boedtker	NULL
,	NULL
H.	NULL
RNA	NULL
molecular	NULL
weight	NULL
determinations	NULL
by	NULL
gel	NULL
electrophoresis	NULL
under	NULL
denaturing	NULL
conditions	NULL
,	NULL
a	NULL
critical	NULL
reexamination	NULL
.	NULL

Biochemistry	NULL
,	NULL
16	NULL
:	NULL
4743-4751	NULL
,	NULL
1977	NULL
.	NULL

39	NULL
.	NULL

Maniatis	NULL
,	NULL
T.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Sambrook	NULL
,	NULL
J.	NULL
Molecular	NULL
Cloning	NULL
.	NULL

A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
:	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Labo-ratory	NULL
,	NULL
1982	NULL
.	NULL

40	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
Allegretto	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Okino	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
Hattori	NULL
,	NULL
K.	NULL
,	NULL
Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
Oncogene	NULL
jun	NULL
encodes	NULL
a	NULL
sequence-specific	NULL
trans-activator	NULL
similar	NULL
to	NULL
AP-1	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
332	NULL
:	NULL
166-171	NULL
,	NULL
1988	NULL
.	NULL

41	NULL
.	NULL

Curran	NULL
,	NULL
T.	NULL
,	NULL
McConnell	NULL
,	NULL
W.	NULL
P.	NULL
,	NULL
Van-Straten	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
Structure	NULL
of	NULL
the	NULL
FB	NULL
)	NULL
murine	NULL
osteosarcoma	NULL
virus	NULL
genome	NULL
:	NULL
molecular	NULL
cloning	NULL
of	NULL
its	NULL
associated	NULL
helper	NULL
virus	NULL
and	NULL
the	NULL
cellular	NULL
homology	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
from	NULL
mouse	NULL
and	NULL
human	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
3	NULL
:	NULL
914-921	NULL
,	NULL
1983	NULL
.	NULL

